CN1483737A - 非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒 - Google Patents
非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒 Download PDFInfo
- Publication number
- CN1483737A CN1483737A CNA031166571A CN03116657A CN1483737A CN 1483737 A CN1483737 A CN 1483737A CN A031166571 A CNA031166571 A CN A031166571A CN 03116657 A CN03116657 A CN 03116657A CN 1483737 A CN1483737 A CN 1483737A
- Authority
- CN
- China
- Prior art keywords
- leu
- val
- thr
- ser
- ala
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 53
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 51
- 241000315672 SARS coronavirus Species 0.000 title claims abstract description 35
- 238000001514 detection method Methods 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000012634 fragment Substances 0.000 claims abstract description 9
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract description 3
- 102000018358 immunoglobulin Human genes 0.000 claims abstract description 3
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 claims description 124
- 235000018102 proteins Nutrition 0.000 claims description 41
- 238000012360 testing method Methods 0.000 claims description 23
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 14
- 229940088598 enzyme Drugs 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 14
- 239000007787 solid Substances 0.000 claims description 12
- 108020004511 Recombinant DNA Proteins 0.000 claims description 9
- 238000005516 engineering process Methods 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 230000002285 radioactive effect Effects 0.000 claims description 6
- 108020004414 DNA Proteins 0.000 claims description 5
- 230000000840 anti-viral effect Effects 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000746 purification Methods 0.000 claims description 4
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 3
- 238000012408 PCR amplification Methods 0.000 claims description 3
- 125000000539 amino acid group Chemical group 0.000 claims description 3
- 230000003321 amplification Effects 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 238000013461 design Methods 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- 102000012440 Acetylcholinesterase Human genes 0.000 claims description 2
- 108010022752 Acetylcholinesterase Proteins 0.000 claims description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 108010015776 Glucose oxidase Proteins 0.000 claims description 2
- 239000004366 Glucose oxidase Substances 0.000 claims description 2
- 102000003992 Peroxidases Human genes 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- 229940022698 acetylcholinesterase Drugs 0.000 claims description 2
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 2
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 2
- 239000012472 biological sample Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 238000004737 colorimetric analysis Methods 0.000 claims description 2
- 238000013016 damping Methods 0.000 claims description 2
- 238000001506 fluorescence spectroscopy Methods 0.000 claims description 2
- 229940116332 glucose oxidase Drugs 0.000 claims description 2
- 235000019420 glucose oxidase Nutrition 0.000 claims description 2
- 230000036039 immunity Effects 0.000 claims description 2
- 229920000592 inorganic polymer Polymers 0.000 claims description 2
- 238000002372 labelling Methods 0.000 claims description 2
- 239000003550 marker Substances 0.000 claims description 2
- 239000011159 matrix material Substances 0.000 claims description 2
- 229920000620 organic polymer Polymers 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 2
- -1 polyethylene Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 230000008521 reorganization Effects 0.000 claims description 2
- 238000002798 spectrophotometry method Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 abstract description 4
- 230000001900 immune effect Effects 0.000 abstract description 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 241000711902 Pneumovirus Species 0.000 abstract 1
- 241000711573 Coronaviridae Species 0.000 description 118
- 102220369445 c.668T>C Human genes 0.000 description 46
- 102220023257 rs387907546 Human genes 0.000 description 38
- 102220023256 rs387907547 Human genes 0.000 description 35
- 102220023258 rs387907548 Human genes 0.000 description 30
- 102220369446 c.1274G>A Human genes 0.000 description 25
- 102220369447 c.1352G>A Human genes 0.000 description 20
- 101100342977 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-1 gene Proteins 0.000 description 12
- 102220004457 rs11567847 Human genes 0.000 description 11
- 239000000427 antigen Substances 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 101100068676 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) gln-1 gene Proteins 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 102100021277 Beta-secretase 2 Human genes 0.000 description 5
- 101710150190 Beta-secretase 2 Proteins 0.000 description 5
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- PNVLWFYAPWAQMU-CIUDSAMLSA-N Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](N)C(C)C PNVLWFYAPWAQMU-CIUDSAMLSA-N 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- XUUXCWCKKCZEAW-YFKPBYRVSA-N Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CCCN=C(N)N XUUXCWCKKCZEAW-YFKPBYRVSA-N 0.000 description 2
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 101150006914 TRP1 gene Proteins 0.000 description 2
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- BFOYULZBKYOKAN-OLHMAJIHSA-N Asp-Asp-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BFOYULZBKYOKAN-OLHMAJIHSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FCXJJTRGVAZDER-FXQIFTODSA-N Cys-Val-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O FCXJJTRGVAZDER-FXQIFTODSA-N 0.000 description 1
- JVSBYEDSSRZQGV-GUBZILKMSA-N Glu-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O JVSBYEDSSRZQGV-GUBZILKMSA-N 0.000 description 1
- HFKJBCPRWWGPEY-BQBZGAKWSA-N L-arginyl-L-glutamic acid Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O HFKJBCPRWWGPEY-BQBZGAKWSA-N 0.000 description 1
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 1
- PBGDOSARRIJMEV-DLOVCJGASA-N Leu-His-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O PBGDOSARRIJMEV-DLOVCJGASA-N 0.000 description 1
- AVEGDIAXTDVBJS-XUXIUFHCSA-N Leu-Ile-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AVEGDIAXTDVBJS-XUXIUFHCSA-N 0.000 description 1
- GHKXHCMRAUYLBS-CIUDSAMLSA-N Lys-Ser-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O GHKXHCMRAUYLBS-CIUDSAMLSA-N 0.000 description 1
- QZPXMHVKPHJNTR-DCAQKATOSA-N Met-Leu-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O QZPXMHVKPHJNTR-DCAQKATOSA-N 0.000 description 1
- ZUQACJLOHYRVPJ-DKIMLUQUSA-N Phe-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 ZUQACJLOHYRVPJ-DKIMLUQUSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- QBFONMUYNSNKIX-AVGNSLFASA-N Pro-Arg-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O QBFONMUYNSNKIX-AVGNSLFASA-N 0.000 description 1
- MLQVJYMFASXBGZ-IHRRRGAJSA-N Pro-Asn-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O MLQVJYMFASXBGZ-IHRRRGAJSA-N 0.000 description 1
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- DDRBQONWVBDQOY-GUBZILKMSA-N Val-Ala-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DDRBQONWVBDQOY-GUBZILKMSA-N 0.000 description 1
- PYPZMFDMCCWNST-NAKRPEOUSA-N Val-Ile-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N PYPZMFDMCCWNST-NAKRPEOUSA-N 0.000 description 1
- CFIBZQOLUDURST-IHRRRGAJSA-N Val-Tyr-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CS)C(=O)O)N CFIBZQOLUDURST-IHRRRGAJSA-N 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000009351 contact transmission Effects 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940035422 diphenylamine Drugs 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 108010027338 isoleucylcysteine Proteins 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒。它提供了非典型性肺炎病毒特异蛋白质，或其具有结合人免疫球蛋白之免疫活性的片段或衍生物；并利用该通式蛋白质免疫检测人非典型性肺炎病毒的方法及试剂盒。本发明解决了临床对非典型性肺炎病毒感染者的早期快速诊断问题，具有较高的准确性，为临床检测本病提供了快速、准确的诊断方法和试剂盒。
Description
技术领域
本发明涉及人类医学卫生领域，具体地说是一种非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒。
背景技术
非典型性肺炎病毒，即SARS病毒是一种引起严重急性呼吸道疾病综合症(Severe Acute Respiratory Syndrome，SARS)，又称非典型性肺炎的病毒，属冠状病毒(coronavirus)类病毒，基因组共含29,737个核苷酸。造成感染严重时可致人于死，病死率高达4.9％。主要通过近距离空气飞沫和密切接触传播。该病毒目前还没有有效的免疫化学检测方法，只能根据临床症状(高热、干咳、肺部X光检测有阴影等)来诊断，受到很大的局限，只能在受感染者发病后才能作出诊断，且不易与其它肺炎和一般流感区别。本发明根据该病毒的基因组序列分析结果，选取该病毒特有蛋白质和多肽片断，建立一种检测非典型性肺炎病毒抗体的免疫学方法和含有它们的试剂盒。
发明内容
本发明的目的是提供一种非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒。
本发明采用的技术方案如下：
1、一种非典型性肺炎病毒特异蛋白质，它包括非典型性肺炎病毒的蛋白质和经修饰的重组非典型性肺炎病毒蛋白质，或其具有结合人免疫球蛋白之免疫活性的片段或衍生物，具有通式Seq.ID No.--Seq.ID No.118的氨基酸序列的蛋白质。
所说的蛋白质相对应的抗体；是单克隆抗体，或是多克隆抗体。
2、一种非典型性肺炎病毒特异蛋白质临床检测方法，其具体步骤如下：
1)制备上述的蛋白质；
通过本领域技术人员周知的PCR扩增技术和重组DNA技术，流程见附图1，具体如下：
A、设计相应的PCR引物，同时在所用PCR引物中添加编码相应数目氨基酸残基对应的碱基，分别从临床非典型性肺炎病毒标准株中扩增编码上述蛋白质的DNA片段；
B、将所得PCR产物导入合适的表达载体，构建重组DNA；
C、用所得重组DNA转化合适的宿主细胞，在适于目标蛋白质表达的条件下培养如此转化的宿主细胞；
D、回收并纯化目标蛋白质；
2)用纯化上述的蛋白质或抗体包被一种固相支持物；所说的固相支持物包括本领域周知的有机和无机多聚物，为葡聚糖、天然或经修饰的纤维素、聚乙烯、聚苯乙烯；或用胶体金的方法包被到试纸上；
3)用比色法、分光光度法或荧光法测定的酶标记的蛋白质或抗体，或抗体的第二抗体(IgG、IgM、IgA)；标记酶包括但不局限于氧化还原酶类，为催化酶、过氧化物酶、辣根过氧化物酶、葡萄糖氧化酶、β-半乳糖苷酶；碱性磷酸酶；乙酰胆碱酯酶；使用胶体金，或放射性同位素作为标记；
4)将待检测个体的生物学样本及由步骤3)标记的蛋白质加入经包被的固相支持物上，在适合形成抗原抗体免疫结合复合物的条件下孵育一段时间；所述的“适合形成抗原抗体免疫复合物的条件”是指在适当的温度及时间条件下孵育抗原与含抗体的样品的混合物，例如在约0-50摄氏度，标记约30分钟至约48小时。
5)适度清洗去除任何未结合的非典型性肺炎病毒抗体；所用清洗液一般为pH约5-8的磷酸
盐缓冲溶液。
6)定量检测孵育混合物中抗原抗体免疫复合物的存在。可采用多种本领域周知的方法定量检测抗原抗体复合物的形成，如以过氧化物溶液为A液及联苯胺类物质为B液的底物与带有含标记的辣根过氧化物酶的抗原抗体免疫复合物作用，显色后在波长为450nm(参比波长630nm)酶标仪读取吸光值；将所得读数与阴性对照的读数加以比较，判断所测样本的结果。
3、一种非典型性肺炎病毒特异蛋白质临床检测的试剂盒，包括：
1)包被有纯化的蛋白质的固相支持物；相应的经标记的的蛋白质和使用该试剂盒的说明(双抗原夹心法)；
2)包被有纯化的抗体的固相支持物；相应的经标记的抗体和使用该试剂盒的说明(双抗体夹心法)；
3)包被有纯化的蛋白质的固相支持物；相应的第二抗体，该第二抗体是抗IgG抗体和/或抗IgM抗体和使用该试剂盒的说明(Elisa法)。
所说的快速检测非典型性肺炎病毒的试纸，是由喷涂过的蛋白或抗体，及喷涂有胶体金的试纸基质粘合而成；
在上述检测试剂盒中，经标记的非典型性肺炎病毒蛋白质是液体的形式包装在容器中，或便于重构的冻干物的形式置于的包装中。在后一种情况中，检测试剂盒中还优选含有用于重构经标记的非典型性肺炎病毒蛋白质的缓冲液；
在上述检测试剂盒中，还含有提供判断检测结果的相应的范围。
本发明与背景技术相比具有的有益效果是：它解决了临床对非典型性肺炎病毒感染者的早期快速诊断问题，具有较高的准确性，为临床检测本病提供了快速、准确的诊断方法和试剂盒。
附图说明
图1是将PCR产物与载体连接构建重组DNA示意图；
图2是高压液相色谱(HPLC)图。
具体实施方式
实施例1、
一、制备蛋白质：
A、设计相应的PCR引物，同时在所用PCR引物中添加编码相应数目氨基酸残基对应的碱基，其中之一的引物如下：AlL：CGGGATCCGAACTTTAAAATCTGTGTAGC AlR：CCGCTCGAGATTTCTGCAACCAGCTCAAC
分别从临床非典型性肺炎病毒标准株中提取RNA和扩增编码上述蛋白质的DNA片段；提取RNA的方法可采用普通分子生物学实验手册，如“分子克隆”介绍的方法，也可以采用商业试剂盒，如TrizolR，按说明书进行，然后加入反向引物和逆转录酶，合成cDNA；采用商品化试剂盒，如InvitrogenTM公司的SuperScript试剂盒，按说明书步骤合成cDNA；再利用PCR技术扩增编码上述蛋白质的DNA片段。PCR反应体系的组成为一般的标准组成，包括：PCR反应缓冲液(Tris.Cl125mM PH8.1；(NH4)2SO4 125mM；MgCl2 12.5mM；BSA 1mg/ml；Formamide 25％)；反应条件指：模板变性温度为92℃-98℃，优选的：95℃，时间为10秒-10分钟，优选的：30秒；模板退火温度为45℃--65℃，优选的：52℃，时间为10秒-10分钟，优选的：30秒；模板延伸温度为65℃--85℃，优选的：70℃，时间为10秒-10分钟，优选的：40秒；循环20--40次，优选的：30次。
B、将所得PCR产物导入合适的表达载体，如附图1所示的pET-28质粒，构建重组DNA；
1μg的质粒DNA于37℃下经NdeI和XhoI酶完全酶切，酚/氯仿抽提，-20℃下无水乙醇沉淀过夜。离心后沉淀溶于13μl H2O。经过NdeI和XhoI酶充分酶切的PCR产物与上述预酶切的质粒连接。
C、用所得重组DNA转化合适的宿主细胞，在适于目标蛋白质表达的条件下培养如此转化的宿主细胞；
转化至大肠杆菌ER2566，涂布含有200μg/ml氨苄青霉素的LB选择平板。37℃过夜培养。构建过程参见图1。所述连接及转化的方法和条件参见，J.萨姆布雷奇等著的《分子克隆实验指南》(Molecular Cloning：A LaboratoryManual)P672-849(科学出版社，1998)
从转化平板上挑取抗性菌落，提取质粒并电泳检查，筛选重组子。通过限制性内切酶NdeI和XhoI酶切分析，筛选含有正确插入的目的基因的重组子。对所得含有插入片段的重组质粒测序，确证在PCR过程中目的基因片段未发生变异或出现差错。
D、回收并纯化目标蛋白质；
将选定的重组子菌株接种于含200μg/ml氨苄青霉素的LB培养基中，置于恒温摇床培养，37℃培养至菌液0D值约0.6后加入1mM IPTG诱导，30℃继续培养2小时。然后将发酵培养物离心收集菌体沉淀。用超声波将所得细菌菌体破碎后再次离心，收集上清液。利用金属镍-Sepharose(Pharmacia公司)的亲和层析柱进行蛋白的分离纯化(洗脱条件0.02M pH7.4磷酸盐缓冲溶液(PBS)，洗脱速度1ml/分钟)。经充分洗涤去除非特异性结合的蛋白质后，分离并收集与金属镍-Sepharose结合的表达蛋白，进行SDS-PAGE电泳和高压液相色谱分析。
附图2为经纯化的蛋白质的高压液相色谱图。
二、间接法检测非典型性肺炎病毒抗体
1)每次试验设空白对照、阴性对照和阳性对照各1孔。空白孔不加液体；阴、阳性对照无需稀释直接取50μl加入阴、阳性对照孔中；其余检测孔加入样品稀释液，每孔100μl，再加入待测样品10μl。充分混匀，贴上封口胶，置37℃温育30分钟。
2)将50倍浓缩洗板液用双蒸水50倍稀释后用于洗涤板孔。
3)弃去各孔中样品，每孔加满洗液，静置数秒后弃去，重复5次，拍干。
4)每孔加入酶标抗人IgG工作液100μl，贴上封口胶。置37℃温育20分钟。
5)弃去各孔中液体，用洗板液反复洗涤5次，拍干。
6)每孔加入底物液A 50μl，再加入底物液B 50μl，轻拍混匀，置37℃避光温育10分钟。
7)显色完毕后，每孔加入终止液50μl，轻拍混匀，立即以空白孔调零，置酶标仪450nm波长下测定OD值(参考波长为630nm)。实施例2、双抗原夹心法检测非典型性肺炎病毒抗体
在96孔微孔反应板上加入预先用0.02M pH9.6的碳酸盐缓冲液(CB)稀释抗原至最适浓度的包被液，4℃静置24小时，加入含0.1％TW-20的0.02M pH7.4 PBS洗涤液(PBS-T)加满各孔，静置数秒后弃去，重复清洗两次。每孔加入200μl入1％牛血清白蛋白(BSA)和1％脱脂奶粉的0.02M pH7.4磷酸盐缓冲液(PBS)，4℃下封闭2小时。弃去封闭液，室温下晾干，用铝薄袋封板，4℃保藏待用。在微孔反应板孔中加入预先用酶标抗原稀释液(20％山羊血清，1％酪蛋白，0.02MPBS，pH7.4)以优化好的浓度稀释的SARS冠状病毒抗原相应的酶标抗原，每孔50μl，再加入15个来自不同待检测的受试者血清，37℃温育60分钟。然后用含0.1％TW-20的0.02M PBS-T洗涤液加满各孔，静置数秒后弃去，重复清洗5次。每孔中加入50μl由0.06％过氧化脲(Sigma)0.01M pH4.5的醋酸盐缓冲液组成的酶作用底物A液以及50μl由0.06％TMB(Sigma)0.01M pH4.5的柠檬酸盐缓冲液组成的酶作用底物B液，37℃温育15分钟。每孔中加入50μl的2MH2SO4终止反应。在酶标仪(Dynatech MR 4100)上读取450nm处的吸光值(以630为参比波长)。其中阳性对照和阴性对照均为经过临床确诊及其他可能的方法复核的人血清，根据实预先确定的阈值判定样本结果，高于阈值的样本为非典型性肺炎病毒阳性。
氨基酸序列表：<110>杭州华大基因研发中心<120>一种检测非典型性肺炎病毒抗体的试剂盒<160>75<170>PatentIn Version 3.1<210>1<211>13<212>PRT<213>SARS coronavirus<400>1Asn Phe Lys Ile Cys Val Ala Val Ala Arg Leu His Ala1 5 10 13<210>2<211>154<212>PRT<213>SARS coronavirus<400>2Leu Asp Asp Thr Val Tyr Cys Pro Arg His Val Ile Cys Thr Ala Glu1 5 10 15Asp Met Leu Asn Pro Asn Tyr Glu Asp Leu Leu Ile Arg Lys Ser Asn
20 25 30His Ser Phe Leu Val Gln Ala Gly Asn Val Gln Leu Arg Val Ile Gly
35 40 45His Ser Met Gln Asn Cys Leu Leu Arg Leu Lys Val Asp Thr Ser Asn
50 55 60Pro Lys Thr Pro Lys Tyr Lys Phe Val Arg Ile Gln Pro Gly Gln Thr65 70 75 80Phe Ser Val Leu Ala Cys Tyr Asn Gly Ser Pro Ser Gly Val Tyr Gln
85 90 95Cys Ala Met Arg Pro Asn His Thr Ile Lys Gly Ser Phe Leu Asn Gly
100 105 110Ser Cys Gly Ser Val Gly Phe Asn Ile Asp Tyr Asp Cys Val Ser Phe
115 120 125Cys Tyr Met His His Met Glu Leu Pro Thr Gly Val His Ala Gly Thr
130 135 140Asp Leu Glu Gly Lys Phe Tyr Gly Pro Phe145 150 154<210>3<211>146<212>PRT<213>SARS coronavirus<400>3His Ala Gly Thr Asp Leu Glu Gly Lys Phe Tyr Gly Pro Phe Val Asp1 5 10 15Arg Gln Thr Ala Gln Ala Ala Gly Thr Asp Thr Thr Ile Thr Leu Asn
20 25 30Val Leu Ala Trp Leu Tyr Ala Ala Val Ile Asn Gly Asp Arg Trp Phe
35 40 45Leu Asn Arg Phe Thr Thr Thr Leu Asn Asp Phe Asn Leu Val Ala Met
50 55 60Lys Tyr Asn Tyr Glu Pro Leu Thr Gln Asp His Val Asp Ile Leu Gly65 70 75 80Pro Leu Ser Ala Gln Thr Gly Ile Ala Val Leu Asp Met Cys Ala Ala
85 90 95Leu Lys Glu Leu Leu Gln Asn Gly Met Asn Gly Arg Thr Ile Leu Gly
100 105 110Ser Thr Ile Leu Glu Asp Glu Phe Thr Pro Phe Asp Val Val Arg Gln
115 120 125Cys Ser Gly Val Thr Phe Gln Gly Lys Phe Lys Lys Ile Val Lys Gly
130 135 140Thr His145 146<210>4<211>147<212>PRT<213>SARS coronavirus<400>4Phe Gln Gly Lys Phe Lys Lys Ile Val Lys Gly Thr His His Trp Met1 5 10 15Leu Leu Thr Phe Leu Thr Ser Leu Leu Ile Leu Val Gln Ser Thr Gln
20 25 30Trp Ser Leu Phe Phe Phe Val Tyr Glu Asn Ala Phe Leu Pro Phe Thr
35 40 45Leu Gly Ile Met Ala Ile Ala Ala Cys Ala Met Leu Leu Val Lys His
50 55 60Lys His Ala Phe Leu Cys Leu Phe Leu Leu Pro Ser Leu Ala Thr Val65 70 75 80Ala Tyr Phe Asn Met Val Tyr Met Pro Ala Ser Trp Val Met Arg Ile
85 90 95Met Thr Trp Leu Glu Leu Ala Asp Thr Ser Leu Ser Gly Tyr Arg Leu
100 105 110Lys Asp Cys Val Met Tyr Ala Ser Ala Leu Val Leu Leu Ile Leu Met
115 120 125Thr Ala Arg Thr Val Tyr Asp Asp Ala Ala Arg Arg Val Trp Thr Leu
130 135 140Met Asn Val145 147<210>5<211>148<212>PRT<213>SARS coronavirus<400>5Tyr Asp Asp Ala Ala Arg Arg Val Trp Thr Leu Met Asn Val Ile Thr1 5 10 l5Leu Val Tyr Lys Val Tyr Tyr Gly Asn Ala Leu Asp Gln Ala Ile Ser
20 25 30Met Trp Ala Leu Val Ile Ser Val Thr Ser Asn Tyr Ser Gly Val Val
35 40 45Thr Thr Ile Met Phe Leu Ala Arg Ala Ile Val Phe Val Cys Val Glu
50 55 60Tyr Tyr Pro Leu Leu Phe Ile Thr Gly Asn Thr Leu Gln Cys Ile Met65 70 75 80Leu Val Tyr Cys Phe Leu Gly Tyr Cys Cys Cys Cys Tyr Phe Gly Leu
85 90 95Phe Cys Leu Leu Asn Arg Tyr Phe Arg Leu Thr Leu Gly Val Tyr Asp
100 105 110Tyr Leu Val Ser Thr Gln Glu Phe Arg Tyr Met Asn Ser Gln Gly Leu
115 120 125Leu Pro Pro Lys Ser Ser Ile Asp Ala Phe Lys Leu Asn Ile Lys Leu
130 135 140Leu Gly Ile Gly145 148<210>6<211>150<212>PRT<213>SARS coronavirus<400>6Lys Ser Ser Ile Asp Ala Phe Lys Leu Asn Ile Lys Leu Leu Gly Ile1 5 10 15Gly Gly Lys Pro Cys Ile Lys Val Ala Thr Val Gln Ser Lys Met Ser
20 25 30Asp Val Lys Cys Thr Ser Val Val Leu Leu Ser Val Leu Gln Gln Leu
35 40 45Arg Val Glu Ser Ser Ser Lys Leu Trp Ala Gln Cys Val Gln Leu His
50 55 60Asn Asp Ile Leu Leu Ala Lys Asp Thr Thr Glu Ala Phe Glu Lys Met65 70 75 80Val Ser Leu Leu Ser Val Leu Leu Ser Met Gln Gly Ala Val Asp Ile
85 90 95Asn Arg Leu Cys Glu Glu Met Leu Asp Asn Arg Ala Thr Leu Gln Ala
100 105 110Ile Ala Ser Glu Phe Ser Ser Leu Pro Ser Tyr Ala Ala Tyr Ala Thr
115 120 125Ala Gln Glu Ala Tyr Glu Gln Ala Val Ala Asn Gly Asp Ser Glu Val
130 135 140Val Leu Lys Lys Leu Lys145 150<210>7<211>157<212>PRT<213>SARS coronavirus<400>7Gly Thr Glu Asn Leu Val Ile Glu Gly Pro Thr Thr Cys Gly Tyr Leu1 5 10 15Pro Thr Asn Ala Val Val Lys Met Pro Cys Pro Ala Cys Gln Asp Pro
20 25 30Glu Ile Gly Pro Glu His Ser Val Ala Asp Tyr His Asn His Ser Asn
35 40 45Ile Glu Thr Arg Leu Arg Lys Gly Gly Arg Thr Arg Cys Phe Gly Gly
50 55 60Cys Val Phe Ala Tyr Val Gly Cys Tyr Asn Lys Arg Ala Tyr Trp Val65 70 75 80Pro Arg Ala Ser Ala Asp Ile Gly Ser Gly His Thr Gly Ile Thr Gly
85 90 95Asp Asn Val Glu Thr Leu Asn Glu Asp Leu Leu Glu Ile Leu Ser Arg
100 105 110Glu Arg Val Asn Ile Asn Ile Val Gly Asp Phe His Leu Asn Glu Glu
115 120 125Val Ala Ile Ile Leu Ala Ser Phe Ser Ala Ser Thr Ser Ala Phe Ile
130 135 140Asp Thr Ile Lys Ser Leu Asp Tyr Lys Ser Phe Lys Thr145 150 155 157<210>8<211>147<212>PRT<213>SARS coronavirus<400>8Val Ala Asn Gly Asp Ser Glu Val Val Leu Lys Lys Leu Lys Lys Ser1 5 10 15Leu Asn Val Ala Lys Ser Glu Phe Asp Arg Asp Ala Ala Met Gln Arg
20 25 30Lys Leu Glu Lys Met Ala Asp Gln Ala Met Thr Gln Met Tyr Lys Gln
35 40 45Ala Arg Ser Glu Asp Lys Arg Ala Lys Val Thr Ser Ala Met Gln Thr
50 55 60Met Leu Phe Thr Met Leu Arg Lys Leu Asp Asn Asp Ala Leu Asn Asn65 70 75 80Ile Ile Asn Asn Ala Arg Asp Gly Cys Val Pro Leu Asn Ile Ile Pro
85 90 95Leu Thr Thr Ala Ala Lys Leu Met Val Val Val Pro Asp Tyr Gly Thr
100 105 110Tyr Lys Asn Thr Cys Asp Gly Asn Thr Phe Thr Tyr Ala Ser Ala Leu
115 120 125Trp Glu Ile Gln Gln Val Val Asp Ala Asp Ser Lys Ile Val Gln Leu
130 135 140Ser Glu Ile145 147<210>9<211>153<212>PRT<213>SARS coronavirus<400>9Val Val Asp Ala Asp Ser Lys Ile Val Gln Leu Ser Glu Ile Asn Met1 5 10 15Asp Asn Ser Pro Asn Leu Ala Trp Pro Leu Ile Val Thr Ala Leu Arg
20 25 30Ala Asn Ser Ala Val Lys Leu Gln Asn Asn Glu Leu Ser Pro Val Ala
35 40 45Leu Arg Gln Met Ser Cys Ala Ala Gly Thr Thr Gln Thr Ala Cys Thr
50 55 60Asp Asp Asn Ala Leu Ala Tyr Tyr Asn Asn Ser Lys Gly Gly Arg Phe65 70 75 80Val Leu Ala Leu Leu Ser Asp His Gln Asp Leu Lys Trp Ala Arg Phe
85 90 95Pro Lys Ser Asp Gly Thr Gly Thr Ile Tyr Thr Glu Leu Glu Pro Pro
100 105 110Cys Arg Phe Val Thr Asp Thr Pro Lys Gly Pro Lys Val Lys Tyr Leu
115 120 125Tyr Phe Ile Lys Gly Leu Asn Asn Leu Asn Arg Gly Met Val Leu Gly
130 135 140Ser Leu Ala Ala Thr Val Arg Leu Gln145 150 153<210>10<211>148<212>PRT<213>SARS coronavirus<400>10Gly Leu Asn Asn Leu Asn Arg Gly Met Val Leu Gly Ser Leu Ala Ala1 5 10 15Thr Val Arg Leu Gln Ala Gly Asn Ala Thr Glu Val Pro Ala Asn Ser
20 25 30Thr Val Leu Ser Phe Cys Ala Phe Ala Val Asp Pro Ala Lys Ala Tyr
35 40 45Lys Asp Tyr Leu Ala Ser Gly Gly Gln Pro Ile Thr Asn Cys Val Lys
50 55 60Met Leu Cys Thr His Thr Gly Thr Gly Gln Ala Ile Thr Val Thr Pro65 70 75 80Glu Ala Asn Met Asp Gln Glu Ser Phe Gly Gly Ala Ser Cys Cys Leu
85 90 95Tyr Cys Arg Cys His Ile Asp His Pro Asn Pro Lys Gly Phe Cys Asp
100 105 110Leu Lys Gly Lys Tyr Val Gln Ile Pro Thr Thr Cys Ala Asn Asp Pro
115 120 125Val Gly Phe Thr Leu Arg Asn Thr Val Cys Thr Val Cys Gly Met Trp
130 135 140Lys Gly Tyr Gly145 148<210>11<211>40<212>PRT<213>SARS coronavirus<400>11Arg Asn Thr Val Cys Thr Val Cys Gly Met Trp Lys Gly Tyr Gly Cys1 5 10 15Ser Cys Asp Gln Leu Arg Glu Pro Leu Met Gln Ser Ala Asp Ala Ser
20 25 30Thr Phe Leu Asn Gly Phe Ala Val
35 40<210>12<211>150<212>PRT<213>SARS coronavirus<400>12Met Val Pro His Ile Ser Arg Gln Arg Leu Thr Lys Tyr Thr Met Ala1 5 10 15Asp Leu Val Tyr Ala Leu Arg His Phe Asp Glu Gly Asn Cys Asp Thr
20 25 30Leu Lys Glu Ile Leu Val Thr Tyr Asn Cys Cys Asp Asp Asp Tyr Phe
35 40 45Asn Lys Lys Asp Trp Tyr Asp Phe Val Glu Asn Pro Asp Ile Leu Arg
50 55 60Val Tyr Ala Asn Leu Gly Glu Arg Val Arg Gln Ser Leu Leu Lys Thr65 70 75 80Val Gln Phe Cys Asp Ala Met Arg Asp Ala Gly Ile Val Gly Val Leu
85 90 95Thr Leu Asp Asn Gln Asp Leu Asn Gly Asn Trp Tyr Asp Phe Gly Asp
100 105 110Phe Val Gln Val Ala Pro Gly Cys Gly Val Pro Ile Val Asp Ser Tyr
115 120 125Tyr Ser Leu Leu Met Pro Ile Leu Thr Leu Thr Arg Ala Leu Ala Ala
130 135 140Glu Ser His Met Asp Ala145 150<210>13<211>146<212>PRT<213>SARS coronavirus<400>13Ile Leu Thr Leu Thr Arg Ala Leu Ala Ala Glu Ser His Met Asp Ala1 5 10 15Asp Leu Ala Lys Pro Leu Ile Lys Trp Asp Leu Leu Lys Tyr Asp Phe
20 25 30Thr Glu Glu Arg Leu Cys Leu Phe Asp Arg Tyr Phe Lys Tyr Trp Asp
35 40 45Gln Thr Tyr His Pro Asn Cys Ile Asn Cys Leu Asp Asp Arg Cys Ile
50 55 60Leu His Cys Ala Asn Phe Asn Val Leu Phe Ser Thr Val Phe Pro Pro65 70 75 80Thr Ser Phe Gly Pro Leu Val Arg Lys Ile Phe Val Asp Gly Val Pro
85 90 95Phe Val Val Ser Thr Gly Tyr His Phe Arg Glu Leu Gly Val Val His
100 105 110Asn Gln Asp Val Asn Leu His Ser Ser Arg Leu Ser Phe Lys Glu Leu
115 120 125Leu Val Tyr Ala Ala Asp Pro Ala Met His Ala Ala Ser Gly Asn Leu
130 135 140Leu Leu145 146<210>14<211>151<212>PRT<213>SARS coronavirus<400>14Ala Ala Asp Pro Ala Met His Ala Ala Ser Gly Asn Leu Leu Leu Asp1 5 10 15Lys Arg Thr Thr Cys Phe Ser Val Ala Ala Leu Thr Asn Asn Val Ala
20 25 30Phe Gln Thr Val Lys Pro Gly Asn Phe Asn Lys Asp Phe Tyr Asp Phe
35 40 45Ala Val Ser Lys Gly Phe Phe Lys Glu Gly Ser Ser Val Glu Leu Lys
50 55 60His Phe Phe Phe Ala Gln Asp Gly Asn Ala Ala Ile Ser Asp Tyr Asp65 70 75 80Tyr Tyr Arg Tyr Asn Leu Pro Thr Met Cys Asp Ile Arg Gln Leu Leu
85 90 95Phe Val Val Glu Val Val Asp Lys Tyr Phe Asp Cys Tyr Asp Gly Gly
100 105 110Cys Ile Asn Ala Asn Gln Val Ile Val Asn Asn Leu Asp Lys Ser Ala
115 120 125Gly Phe Pro Phe Asn Lys Trp Gly Lys Ala Arg Leu Tyr Tyt Asp Ser
130 135 140Met Ser Tyr Glu Asp Gln Asp145 150 151<210>15<211>148<212>PRT<213>SARS coronavirus<400>15Lys Trp Gly Lys Ala Arg Leu Tyr Tyr Asp Ser Met Ser Tyr Glu Asp1 5 10 15Gln Asp Ala Leu Phe Ala Tyr Thr Lys Arg Asn Val Ile Pro Thr Ile
20 25 30Thr Gln Met Asn Leu Lys Tyr Ala Ile Ser Ala Lys Asn Arg Ala Arg
35 40 45Thr Val Ala Gly Val Ser Ile Cys Ser Thr Met Thr Asn Arg Gln Phe
50 55 60His Gln Lys Leu Leu Lys Ser Ile Ala Ala Thr Arg Gly Ala Thr Val65 70 75 80Val Ile Gly Thr Ser Lys Phe Tyr Gly Gly Trp His Asn Met Leu Lys
85 90 95Thr Val Tyr Ser Asp Val Glu Thr Pro His Leu Met Gly Trp Asp Tyr
100 105 110Pro Lys Cys Asp Arg Ala Met Pro Asn Met Leu Arg Ile Met Ala Ser
115 120 125Leu Val Leu Ala Arg Lys His Asn Thr Cys Cys Asn Leu Ser His Arg
130 135 140Phe Tyr Arg Leu145 148<210>16<211>154<212>PRT<213>SARS coronavirus<400>16His Asn Thr Cys Cys Asn Leu Ser His Arg Phe Tyr Arg Leu Ala Asn1 5 10 15Glu Cys Ala Gln Val Leu Ser Glu Met Val Met Cys Gly Gly Ser Leu
20 25 30Tyr Val Lys Pro Gly Gly Thr Ser Ser Gly Asp Ala Thr Thr Ala Tyr
35 40 45Ala Asn Ser Val Phe Asn Ile Cys Gln Ala Val Thr Ala Asn Val Asn
50 55 60Ala Leu Leu Ser Thr Asp Gly Asn Lys Ile Ala Asp Lys Tyr Val Arg65 70 75 80Asn Leu Gln His Arg Leu Tyr Glu Cys Leu Tyr Arg Asn Arg Asp Val
85 90 95Asp His Glu Phe Val Asp Glu Phe Tyr Ala Tyr Leu Arg Lys His Phe
100 105 110Ser Met Met Ile Leu Ser Asp Asp Ala Val Val Cys Tyr Asn Ser Asn
115 120 125Tyr Ala Ala Gln Gly Leu Val Ala Ser Ile Lys Asn Phe Lys Ala Val
130 135 140Leu Tyr Tyr Gln Asn Asn Val Phe Met Ser145 150 154<210>17<211>148<212>PRT<213>SARS coronavirus<400>17Val Ala Ser Ile Lys Asn Phe Lys Ala Val Leu Tyr Tyr Gln Asn Asn1 5 10 15Val Phe Met Ser Glu Ala Lys Cys Trp Thr Glu Thr Asp Leu Thr Lys
20 25 30Gly Pro His Glu Phe Cys Ser Gln His Thr Met Leu Val Lys Gln Gly
35 40 45Asp Asp Tyr Val Tyr Leu Pro Tyr Pro Asp Pro Ser Arg Ile Leu Gly
50 55 60Ala Gly Cys Phe Val Asp Asp Ile Val Lys Thr Asp Gly Thr Leu Met65 70 75 80Ile Glu Arg Phe Val Ser Leu Ala Ile Asp Ala Tyr Pro Leu Thr Lys
85 90 95His Pro Asn Gln Glu Tyr Ala Asp Val Phe His Leu Tyr Leu Gln Tyr
100 105 110Ile Arg Lys Leu His Asp Glu Leu Thr Gly His Met Leu Asp Met Tyr
115 120 125Ser Val Met Leu Thr Asn Asp Asn Thr Ser Arg Tyr Trp Glu Pro Glu
130 135 140Phe Tyr Glu Ala145 148<210>18<211>146<212>PRT<213>SARS coronavirus<400>18Ser Phe Ser Ala Ser Thr Ser Ala Phe Ile Asp Thr Ile Lys Ser Leu1 5 10 15Asp Tyr Lys Ser Phe Lys Thr Ile Val Glu Ser Cys Gly Asn Tyr Lys
20 25 30Val Thr Lys Gly Lys Pro Val Lys Gly Ala Trp Asn Ile Gly Gln Gln
35 40 45Arg Ser Val Leu Thr Pro Leu Cys Gly Phe Pro Ser Gln Ala Ala Gly
50 55 60Val Ile Arg Ser Ile Phe Ala Arg Thr Leu Asp Ala Ala Asn His Ser65 70 75 80Ile Pro Asp Leu Gln Arg Ala Ala Val Thr Ile Leu Asp Gly Ile Ser
85 90 95Glu Gln Ser Leu Arg Leu Val Asp Ala Met Val Tyr Thr Ser Asp Leu
100 105 110Leu Thr Asn Ser Val Ile Ile Met Ala Tyr Val Thr Gly Gly Leu Val
115 120 125Gln Gln Thr Ser Gln Trp Leu Ser Asn Leu Leu Gly Thr Thr Val Glu
130 135 140Lys Leu145 146<210>19<211>151<212>PRT<213>SARS coronavirus<400>19Thr Asn Asp Asn Thr Ser Arg Tyr Trp Glu Pro Glu Phe Tyr Glu Ala1 5 10 15Met Tyr Thr Pro His Thr Val Leu Gln Ala Val Gly Ala Cys Val Leu
20 25 30Cys Asn Ser Gln Thr Ser Leu Arg Cys Gly Ala Cys Ile Arg Arg Pro
35 40 45Phe Leu Cys Cys Lys Cys Cys Tyr Asp His Val Ile Ser Thr Ser His
50 55 60Lys Leu Val Leu Ser Val Asn Pro Tyr Val Cys Asn Ala Pro Gly Cys65 70 75 80Asp Val Thr Asp Val Thr Gln Leu Tyr Leu Gly Gly Met Ser Tyr Tyr
85 90 95Cys Lys Ser His Lys Pro Pro Ile Ser Phe Pro Leu Cys Ala Asn Gly
100 105 110Gln Val Phe Gly Leu Tyr Lys Asn Thr Cys Val Gly Ser Asp Asn Val
115 120 125Thr Asp Phe Asn Ala Ile Ala Thr Cys Asp Trp Thr Asn Ala Gly Asp
130 135 140Tyr Ile Leu Ala Asn Thr Cys145 150 151<210>20<211>148<212>PRT<213>SARS coronavirus<400>20Ala Thr Cys Asp Trp Thr Asn Ala Gly Asp Tyr Ile Leu Ala Asn Thr1 5 10 15Cys Thr Glu Arg Leu Lys Leu Phe Ala Ala Glu Thr Leu Lys Ala Thr
20 25 30Glu Glu Thr Phe Lys Leu Ser Tyr Gly Ile Ala Thr Val Arg Glu Val
35 40 45Leu Ser Asp Arg Glu Leu His Leu Ser Trp Glu Val Gly Lys Pro Arg
50 55 60Pro Pro Leu Asn Arg Asn Tyr Val Phe Thr Gly Tyr Arg Val Thr Lys65 70 75 80Asn Ser Lys Val Gln Ile Gly Glu Tyr Thr Phe Glu Lys Gly Asp Tyr
85 90 95Gly Asp Ala Val Val Tyr ArgGly Thr Thr Thr Tyr Lys Leu Asn Val
100 105 110Gly Asp Tyr Phe Val Leu Thr Ser His Thr Val Met Pro Leu Ser Ala
115 120 125Pro Thr Leu Val Pro Gln Glu His Tyr Val Arg Ile Thr Gly Leu Tyr
130 135 140Pro Thr Leu Asn145 148<210>21<211>147<212>PRT<213>SARS coronavirus<400>21Glu His Tyr Val Arg Ile Thr Gly Leu Tyr Pro Thr Leu Asn Ile Ser1 5 10 15Asp Glu Phe Ser Ser Asn Val Ala Asn Tyr Gln Lys Val Gly Met Gln
20 25 30Lys Tyr Ser Thr Leu Gln Gly Pro Pro Gly Thr Gly Lys Ser His Phe
35 40 45Ala Ile Gly Leu Ala Leu Tyr Tyr Pro Ser Ala Arg Ile Val Tyr Thr
50 55 60Ala Cys Ser His Ala Ala Val Asp Ala Leu Cys Glu Lys Ala Leu Lys65 70 75 80Tyr Leu Pro Ile Asp Lys Cys Ser Arg Ile Ile Pro Ala Arg Ala Arg
85 90 95Val Glu Cys Phe Asp Lys Phe Lys Val Asn Ser Thr Leu Glu Gln Tyr
100 105 110Val Phe Cys Thr Val Asn Ala Leu Pro Glu Thr Thr Ala Asp Ile Val
115 120 125Val Phe Asp Glu Ile Ser Met Ala Thr Asn Tyr Asp Leu Ser Val Val
130 135 140Asn Ala Arg145 147<210>22<211>149<212>PRT<213>SARS coronavirus<400>22Glu Ile Ser Met Ala Thr Asn Tyr Asp Leu Ser Val Val Asn Ala Arg1 5 10 15Leu Arg Ala Lys His Tyr Val Tyr Ile Gly Asp Pro Ala Gln Leu Pro
20 25 30Ala Pro Arg Thr Leu Leu Thr Lys Gly Thr Leu Glu Pro Glu Tyr Phe
35 40 45Asn Ser Val Cys Arg Leu Met Lys Thr Ile Gly Pro Asp Met Phe Leu
50 55 60Gly Thr Cys Arg Arg Cys Pro Ala Glu Ile Val Asp Thr Val Ser Ala65 70 75 80Leu Val Tyr Asp Asn Lys Leu Lys Ala His Lys Asp Lys Ser Ala Gln
85 90 95Cys Phe Lys Met Phe Tyr Lys Gly Val Ile Thr His Asp Val Ser Ser
100 105 110Ala Ile Asn Arg Pro Gln Ile Gly Val Val Arg Glu Phe Leu Thr Arg
115 120 125Asn Pro Ala Trp Arg Lys Ala Val Phe Ile Ser Pro Tyr Asn Ser Gln
130 135 140Asn Ala Val Ala Ser145 149<210>23<211>150<212>PRT<213>SARS coronavirus<400>23Ala Val Phe Ile Ser Pro Tyr Asn Ser Gln Asn Ala Val Ala Ser Lys1 5 10 15Ile Leu Gly Leu Pro Thr Gln Thr Val Asp Ser Ser Gln Gly Ser Glu
20 25 30Tyr Asp Tyr Val Ile Phe Thr Gln Thr Thr Glu Thr Ala His Ser Cys
35 40 45Asn Val Asn Arg Phe Asn Val Ala Ile Thr Arg Ala Lys Ile Gly Ile
50 55 60Leu Cys Ile Met Ser Asp Arg Asp Leu Tyr Asp Lys Leu Gln Phe Thr65 70 75 80Ser Leu Glu Ile Pro Arg Arg Asn Val Ala Thr Leu Gln Ala Glu Asn
85 90 95Val Thr Gly Leu Phe Lys Asp Cys Ser Lys Ile Ile Thr Gly Leu His
100 105 110Pro Thr Gln Ala Pro Thr His Leu Ser Val Asp Ile Lys Phe Lys Thr
115 120 125Glu Gly Leu Cys Val Asp Ile Pro Gly Ile Pro Lys Asp Met Thr Tyr
130 135 140Arg Arg Leu Ile Ser Met145 150<210>24<211>158<212>PRT<213>SARS coronavirus<400>24Pro Gly Ile Pro Lys Asp Met Thr Tyr Arg Arg Leu Ile Ser Met Met1 5 10 15Gly Phe Lys Met Asn Tyr Gln Val Asn Gly Tyr Pro Asn Met Phe Ile
20 25 30Thr Arg Glu Glu Ala Ile Arg His Val Arg Ala Trp Ile Gly Phe Asp
35 40 45Val Glu Gly Cys His Ala Thr Arg Asp Ala Val Gly Thr Asn Leu Pro
50 55 60Leu Gln Leu Gly Phe Ser Thr Gly Val Asn Leu Val Ala Val Pro Thr65 70 75 80Gly Tyr Val Asp Thr Glu Asn Asn Thr Glu Phe Thr Arg Val Asn Ala
85 90 95Lys Pro Pro Pro Gly Asp Gln Phe Lys His Leu Ile Pro Leu Met Tyr
100 105 110Lys Gly Leu Pro Trp Asn Val Val Arg Ile Lys Ile Val Gln Met Leu
115 120 125Ser Asp Thr Leu Lys Gly Leu Ser Asp Arg Val Val Phe Val Leu Trp
130 135 140Ala His Gly Phe Glu Leu Thr Ser Met Lys Tyr Phe Val Lys145 150 155 158<210>25<211>146<212>PRT<213>SARS coronavirus<400>25Leu Ser Asp Arg Val Val Phe Val Leu Trp Ala His Gly Phe Glu Leu1 5 10 15Thr Ser Met Lys Tyr Phe Val Lys Ile Gly Pro Glu Arg Thr Cys Cys
20 25 30Leu Cys Asp Lys Arg Ala Thr Cys Phe Ser Thr Ser Ser Asp Thr Tyr
35 40 45Ala Cys Trp Asn His Ser Val Gly Phe Asp Tyr Val Tyr Asn Pro Phe
50 55 60Met Ile Asp Val Gln Gln Trp Gly Phe Thr Gly Asn Leu Gln Ser Asn65 70 75 80His Asp Gln His Cys Gln Val His Gly Asn Ala His Val Ala Ser Cys
85 90 95Asp Ala Ile Met Thr Arg Cys Leu Ala Val His Glu Cys Phe Val Lys
100 105 110Arg Val Asp Trp Ser Val Glu Tyr Pro Ile Ile Gly Asp Glu Leu Arg
115 120 125Val Asn Ser Ala Cys Arg Lys Val Gln His Met Val Val Lys Ser Ala
130 135 140Leu Leu145 146<210>26<211>146<212>PRT<213>SARS coronavirus<400>26Arg Lys Val Gln His Met Val Val Lys Ser Ala Leu Leu Ala Asp Lys1 5 10 15Phe Pro Val Leu His Asp Ile Gly Asn Pro Lys Ala Ile Lys Cys Val
20 25 30Pro Gln Ala Glu Val Glu Trp Lys Phe Tyr Asp Ala Gln Pro Cys Ser
35 40 45Asp Lys Ala Tyr Lys Ile Glu Glu Leu Phe Tyr Ser Tyr Ala Thr His
50 55 60His Asp Lys Phe Thr Asp Gly Val Cys Leu Phe Trp Asn Cys Asn Val65 70 75 80Asp Arg Tyr Pro Ala Asn Ala Ile Val Cys Arg Phe Asp Thr Arg Val
85 90 95Leu Ser Asn Leu Asn Leu Pro Gly Cys Asp Gly Gly Ser Leu Tyr Val
100 105 110Asn Lys His Ala Phe His Thr Pro Ala Phe Asp Lys Ser Ala Phe Thr
115 120 125Asn Leu Lys Gln Leu Pro Phe Phe Tyr Tyr Ser Asp Ser Pro Cys Glu
130 135 140Ser His145 146<210>27<211>151<212>PRT<2l3>SARS coronavirus<400>27Pro Phe Phe Tyr Tyr Ser Asp Ser Pro Cys Glu Ser His Gly Lys Gln1 5 10 15Val Val Ser Asp Ile Asp Tyr Val Pro Leu Lys Ser Ala Thr Cys Ile
20 25 30Thr Arg Cys Asn Leu Gly Gly Ala Val Cys Arg His His Ala Asn Glu
35 40 45Tyr Arg Gln Tyr Leu Asp Ala Tyr Asn Met Met Ile Ser Ala Gly Phe
50 55 60Ser Leu Trp Ile Tyr Lys Gln Phe Asp Thr Tyr Asn Leu Trp Asn Thr65 70 75 80Phe Thr Arg Leu Gln Ser Leu Glu Asn Val Ala Tyr Asn Val Val Asn
85 90 95Lys Gly His Phe Asp Gly His Ala Gly Glu Ala Pro Val Ser Ile Ile
100 105 110Asn Asn Ala Val Tyr Thr Lys Val Asp Gly Ile Asp Val Glu Ile Phe
115 120 125Glu Asn Lys Thr Thr Leu Pro Val Asn Val Ala Phe Glu Leu Trp Ala
130 135 140Lys Arg Asn Ile Lys Pro Val145 150 151<210>28<211>148<212>PRT<213>SARS coronavirus<400>28Pro Val Asn Val Ala Phe Glu Leu Trp Ala Lys Arg Asn Ile Lys Pro1 5 10 15Val Pro Glu Ile Lys Ile Leu Asn Asn Leu Gly Val Asp Ile Ala Ala
20 25 30Asn Thr Val Ile Trp Asp Tyr Lys Arg Glu Ala Pro Ala His Val Ser
35 40 45Thr Ile Gly Val Cys Thr Met Thr Asp Ile Ala Lys Lys Pro Thr Glu
50 55 60Ser Ala Cys Ser Ser Leu Thr Val Leu Phe Asp Gly Arg Val Glu Gly65 70 75 80Gln Val Asp Leu Phe Arg Asn Ala Arg Asn Gly Val Leu Ile Thr Glu
85 90 95Gly Ser Val Lys Gly Leu Thr Pro Ser Lys Gly Pro Ala Gln Ala Ser
100 105 110Val Asn Gly Val Thr Leu Ile Gly Glu Ser Val Lys Thr Gln Phe Asn
115 120 125Tyr Phe Lys Lys Val Asp Gly Ile Ile Gln Gln Leu Pro Glu Thr Tyr
130 135 140Phe Thr Gln Ser145 148<210>29<211>144<212>PRT<213>SARS coronavirus<400>29Ser Gly Cys Leu Ile Phe Trp Ala Leu Leu Leu Lys Asn Ser Gly Leu1 5 10 15Ser Leu Asn Gly Leu Arg Arg Asn Leu Val Gln Glu Leu Asn Phe Ser
20 25 30Arg Met Leu Gly Arg Phe Ser Asn Phe Ser Leu Gln Val Phe Leu Thr
35 40 45Ser Ser Arg Val Lys Tyr Arg Leu Leu Gln Ile Thr Ser Arg Ile Val
50 55 60Asn Ala Ser Leu Met Leu Leu Thr Arg His Ser Lys Cys Ala Leu Ile65 70 75 80Lys Ser Leu Ser Leu Ala Gln Ser Cys Asp His Ser Thr Val Lys Ser
85 90 95Ser Ser Leu Lys Ala Arg Asp Phe Thr Val Ser Val Tys Val Ala Arg
100 105 110Ser Ser Cys Asn Tyr Ser Cys Leu Leu Arg His Gln Lys Lys Pro Phe
115 120 125Leu Lys Val Ile His Met Thr Gln Tyr Leu Pro Leu Arg Arg Leu Phe144<210>30<211>150<212>PRT<213>SARS coronavirus<400>30Asp Gly Ile Ile Gln Gln Leu Pro Glu Thr Tyr Phe Thr Gln Ser Arg1 5 10 15Asp Leu Glu Asp Phe Lys Pro Arg Ser Gln Met Glu Thr Asp Phe Leu
20 25 30Glu Leu Ala Met Asp Glu Phe Ile Gln Arg Tyr Lys Leu Glu Gly Tyr
35 40 45Ala Phe Glu His Ile Val Tyr Gly Asp Phe Ser His Gly Gln Leu Gly
50 55 60Gly Leu His Leu Met Ile Gly Leu Ala Lys Arg Ser Gln Asp Ser Pro65 70 75 80Leu Lys Leu Glu Asp Phe Ile Pro Met Asp Ser Thr Val Lys Asn Tyr
85 90 95Phe Ile Thr Asp Ala Gln Thr Gly Ser Ser Lys Cys Val Cys Ser Val
100 105 110Ile Asp Leu Leu Leu Asp Asp Phe Val Glu Ile Ile Lys Ser Gln Asp
115 120 125Leu Ser Val Ile Ser Lys Val Val Lys Val Thr Ile Asp Tyr Ala Glu
130 135 140Ile Ser Phe Met Leu Trp145 150<210>31<211>146<212>PRT<213>SARS coronavirus<400>31Val Val Lys Val Thr Ile Asp Tyr Ala Glu Ile Ser Phe Met Leu Trp1 5 10 15Cys Lys Asp Gly His Val Glu Thr Phe Tyr Pro Lys Leu Gln Ala Ser
20 25 30Arg Ala Trp Gln Pro Gly Val Ala Met Pro Asn Leu Tyr Lys Met Gln
35 40 45Arg Met Leu Leu Glu Lys Cys Asp Leu Gln Asn Tyr Gly Glu Asn Ala
50 55 60Val Ile Pro Lys Gly Ile Met Met Asn Val Ala Lys Tyr Thr Gln Leu65 70 75 80Cys Gln Tyr Leu Asn Thr Leu Thr Leu Ala Val Pro Tyr Asn Met Arg
85 90 95Val Ile His Phe Gly Ala Gly Ser Asp Lys Gly Val Ala Pro Gly Thr
100 105 110Ala Val Leu Arg Gln Trp Leu Pro Thr Gly Thr Leu Leu Val Asp Ser
115 120 125Asp Leu Asn Asp Phe Val Ser Asp Ala Tyr Ser Thr Leu Ile Gly Asp
130 135 140Cys Ala145 146<210>32<211>151<212>PRT<213>SARS coronavirus<400>32Asp Leu Asn Asp Phe Val Ser Asp Ala Tyr Ser Thr Leu Ile Gly Asp1 5 10 15Cys Ala Thr Val His Thr Ala Asn Lys Trp Asp Leu Ile Ile Ser Asp
20 25 30Met Tyr Asp Pro Arg Thr Lys His Val Thr Lys Glu Asn Asp Ser Lys
35 40 45Glu Gly Phe Phe Thr Tyr Leu Cys Gly Phe Ile Lys Gln Lys Leu Ala
50 55 60Leu Gly Gly Ser Ile Ala Val Lys Ile Thr Glu His Ser Trp Asn Ala65 70 75 80Asp Leu Tyr Lys Leu Met Gly His Phe Ser Trp Trp Thr Ala Phe Val
85 90 95Thr Asn Val Asn Ala Ser Ser Ser Glu Ala Phe Leu Ile Gly Ala Asn
100 105 110Tyr Leu Gly Lys Pro Lys Glu Gln Ile Asp Gly Tyr Thr Met His Ala
115 120 125Asn Tyr Ile Phe Trp Arg Asn Thr Asn Pro Ile Gln Leu Ser Ser Tyr
130 135 140Ser Leu Phe Asp Met Ser Lys145 150 151<210>33<21l>149<212>PRT<2l3>SARS coronavirus<400>33Ile Gln Leu Ser Ser Tyr Ser Leu Phe Asp Met Ser Lys Phe Pro Leu1 5 10 15Lys Leu Arg Gly Thr Ala Val Met Ser Leu Lys Glu Asn Gln Ile Asn
20 25 30Asp Met Ile Tyr Ser Leu Leu Glu Lys Gly Arg Leu Ile Ile Arg Glu
35 40 45Asn Asn Arg Val Val Val Ser Ser Asp Ile Leu Val Asn Asn Thr Asn
50 55 60Met Phe Ile Phe Leu Leu Phe Leu Thr Leu Thr Ser Gly Ser Asp Leu65 70 75 80Asp Arg Cys Thr Thr Phe Asp Asp Val Gln Ala Pro Asn Tyr Thr Gln
85 90 95His Thr Ser Ser Met Arg Gly Val Tyr Tyr Pro Asp Glu Ile Phe Arg
100 105 110Ser Asp Thr Leu Tyr Leu Thr Gln Asp Leu Phe Leu Pro Phe Tyr Ser
115 120 125Asn Val Thr Gly Phe His Thr Ile Asn His Thr Phe Gly Asn Pro Val
130 135 140Ile Pro Phe Lys Asp145 149<210>34<211>152<212>PRT<213>SARS coronavirus<400>34Asn Val Thr Gly Phe His Thr Ile Asn His Thr Phe Gly Asn Pro Val1 5 10 15Ile Pro Phe Lys Asp Gly Ile Tyr Phe Ala Ala Thr Glu Lys Ser Asn
20 25 30Val Val Arg Gly Trp Val Phe Gly Ser Thr Met Asn Asn Lys Ser Gln
35 40 45Ser Val Ile Ile Ile Asn Asn Ser Thr Asn Val Val Ile Arg Ala Cys
50 55 60Asn Phe Glu Leu Cys Asp Asn Pro Phe Phe Ala Val Ser Lys Pro Met65 70 75 80Gly Thr Gln Thr His Thr Met Ile Phe Asp Asn Ala Phe Asn Cys Thr
85 90 95Phe Glu Tyr Ile Ser Asp Ala Phe Ser Leu Asp Val Ser Glu Lys Ser
100 105 110Gly Asn Phe Lys His Leu Arg Glu Phe Val Phe Lys Asn Lys Asp Gly
115 120 125Phe Leu Tyr Val Tyr Lys Gly Tyr Gln Pro Ile Asp Val Val Arg Asp
130 135 140Leu Pro Ser Gly Phe Asn Thr Leu145 150 152<210>35<211>152<212>PRT<213>SARS coronavirus<400>35Tyr Gln Pro Ile Asp Val Val Arg Asp Leu Pro Ser Gly Phe Asn Thr1 5 10 15Leu Lys Pro Ile Phe Lys Leu Pro Leu Gly Ile Asn Ile Thr Asn Phe
20 25 30Arg Ala Ile Leu Thr Ala Phe Ser Pro Ala Gln Asp Ile Trp Gly Thr
35 40 45Ser Ala Ala Ala Tyr Phe Val Gly Tyr Leu Lys Pro Thr Thr Phe Met
50 55 60Leu Lys Tyr Asp Glu Asn Gly Thr Ile Thr Asp Ala Val Asp Cys Ser65 70 75 80Gln Asn Pro Leu Ala Glu Leu Lys Cys Ser Val Lys Ser Phe Glu Ile
85 90 95Asp Lys Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val Val Pro Ser Gly
100 105 110Asp Val Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu
115 120 125Val Phe Asn Ala Thr Lys Phe Pro Ser Val Tyr Ala Trp Glu Arg Lys
130 135 140Lys Ile Ser Asn Cys Val Ala Asp145 150 152<210>36<211>153<212>PRT<213>SARS coronavirus<400>36Lys Phe Pro Ser Val Tyr Ala Trp Glu Arg Lys Lys Ile Ser Asn Cys1 5 10 15Val Ala Asp Tyr Ser Val Leu Tyr Asn Ser Thr Phe Phe Ser Thr Phe
20 25 30Lys Cys Tyr Gly Val Ser A1a Thr Lys Leu Asn Asp Leu Cys Phe Ser
35 40 45Asn Val Tyr Ala Asp Ser Phe Val Val Lys Gly Asp Asp Val Arg Gln
50 55 60Ile Ala Pro Gly Gln Thr Gly ValIle Ala Asp Tyr Asn Tyr Lys Leu65 70 75 80Pro Asp Asp Phe Met Gly Cys Val Leu Ala Trp Asn Thr Arg Asn Ile
85 90 95Asp Ala Thr Ser Thr Gly Asn Tyr Asn Tyr Lys Tyr Arg Tyr Leu Arg
100 105 110His Gly Lys Leu Arg Pro Phe Glu Arg Asp Ile Ser Asn Val Pro Phe
115 120 125Ser Pro Asp Gly Lys Pro Cys Thr Pro Pro Ala Leu Asn Cys Tyr Trp
130 135 140Pro Leu Asn Asp Tyr Gly Phe Tyr Thr145 150 153<210>37<211>146<212>PRT<213>SARS coronavirus<400>37Pro Ala Leu Asn Cys Tyr Trp Pro Leu Asn Asp Tyr Gly Phe Tyr Thr1 5 10 15Thr Thr Gly Ile Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe
20 25 30Glu Leu Leu Asn Ala Pro Ala Thr Val Cys Gly Pro Lys Leu Ser Thr
35 40 45Asp Leu Ile Lys Asn Gln Cys Val Asn Phe Asn Phe Asn Gly Leu Thr
50 55 60Gly Thr Gly Val Leu Thr Pro Ser Ser Lys Arg Phe Gln Pro Phe Gln65 70 75 80Gln Phe Gly Arg Asp Val Ser Asp Phe Thr Asp Ser Val Arg Asp Pro
85 90 95Lys Thr Ser Glu Ile Leu Asp Ile Ser Pro Cys Ala Phe Gly Gly Val
100 105 110Ser Val Ile Thr Pro Gly Thr Asn Ala Ser Ser Glu Val Ala Val Leu
115 120 125Tyr Gln Asp Val Asn Cys Thr Asp Val Ser Thr Ala Ile His Ala Asp
130 135 140Gln Leu145 146<210>38<211>147<212>PRT<213>SARS coronavirus<400>38Cys Thr Asp Val Ser Thr Ala Ile His Ala Asp Gln Leu Thr Pro Ala1 5 10 15Trp Arg Ile Tyr Ser Thr Gly Asn Asn Val Phe Gln Thr Gln Ala Gly
20 25 30Cys Leu Ile Gly Ala Glu His Val Asp Thr Ser Tyr Glu Cys Asp Ile
35 40 45Pro Ile Gly Ala Gly Ile Cys Ala Ser Tyr His Thr Val Ser Leu Leu
50 55 60Arg Ser Thr Ser Gln Lys Ser Ile Val Ala Tyr Thr Met Ser Leu Gly65 70 75 80Ala Asp Ser Ser Ile Ala Tyr Ser Asn Asn Thr Ile Ala Ile Pro Thr
85 90 95Asn Phe Ser Ile Ser Ile Thr Thr Glu Val Met Pro Val Ser Met Ala
100 105 110Lys Thr Ser Val Asp Cys Asn Met Tyr Ile Cys Gly Asp Ser Thr Glu
115 120 125Cys Ala Asn Leu Leu Leu Gln Tyr Gly Ser Phe Cys Thr Gln Leu Asn
130 135 140Arg Ala Leu145 147<210>39<211>147<212>PRT<213>SARS coronavirus<400>39Leu Gln Tyr Gly Ser Phe Cys Thr Gln Leu Asn Arg Ala Leu Ser Gly1 5 10 15Ile Ala Ala Glu Gln Asp Arg Asn Thr Arg Glu Val Phe Ala Gln Val
20 25 30Lys Gln Met Tyr Lys Thr Pro Thr Leu Lys Tyr Phe Gly Gly Phe Asn
35 40 45Phe Ser Gln Ile Leu Pro Asp Pro Leu Lys Pro Thr Lys Arg Ser Phe
50 55 60Ile Glu Asp Leu Leu Phe Asn Lys Val Thr Leu Ala Asp Ala Gly Phe65 70 75 80Met Lys Gln Tyr Gly Glu Cys Leu Gly Asp Ile Asn Ala Arg Asp Leu
85 90 95Ile Cys Ala Gln Lys Phe Asn Gly Leu Thr Val Leu Pro Pro Leu Leu
100 105 110Thr Asp Asp Met Ile Ala Ala Tyr Thr Ala Ala Leu Val Ser Gly Thr
115 120 125Ala Thr Ala Gly Trp Thr Phe Gly Ala Gly Ala Ala Leu Gln Ile Pro
130 135 140Phe Ala Met145 147<210>40<211>146<212>PRT<213>SARS coronavirus<400>40Asp Ser His Asp Thr Val Leu Thr Ser Glu Glu Val Val Leu Lys Asn1 5 10 15Gly Glu Leu Glu Ala Leu Glu Thr Pro Val Asp Ser Phe Thr Asn Gly
20 25 30Ala Ile Val Gly Thr Pro Val Cys Val Asn Gly Leu Met Leu Leu Glu
35 40 45Ile Lys Asp Lys Glu Gln Tyr Cys Ala Leu Ser Pro Gly Leu Leu Ala
50 55 60Thr Asn Asn Val Phe Arg Leu Lys Gly Gly Ala Pro Ile Lys Gly Val65 70 75 80Thr Phe Gly Glu Asp Thr Val Trp Glu Val Gln Gly Tyr Lys Asn Val
85 90 95Arg Ile Thr Phe Glu Leu Asp Glu Arg Val Asp Lys Val Leu Asn Glu
100 105 110Lys Cys Ser Val Tyr Thr Val Glu Ser Gly Thr Glu Val Thr Glu Phe
115 120 125Ala Cys Val Val Ala Glu Ala Val Val Lys Thr Leu Gln Pro Val Ser
130 135 140Asp Leu145 146<210>41<211>149<212>PRT<213>SARS coronavirus<400>41Trp Thr Phe Gly Ala Gly Ala Ala Leu Gln Ile Pro Phe Ala Met Gln1 5 10 15Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr Gln Asn Val Leu Tyr
20 25 30Glu Asn Gln Lys Gln Ile Ala Asn Gln Phe Asn Lys Ala Ile Ser Gln
35 40 45Ile Gln Glu Ser Leu Thr Thr Thr Ser Thr Ala Leu Gly Lys Leu Gln
50 55 60Asp Val Val Asn Gln Asn Ala Gln Ala Leu Asn Thr Leu Val Lys Gln65 70 75 80Leu Ser Ser Asn Phe Gly Ala Ile Ser Ser Val Leu Asn Asp Ile Leu
85 90 95Ser Arg Leu Asp Lys Val Glu Ala Glu Val Gln Ile Asp Arg Leu Ile
100 105 110Thr Gly Arg Leu Gln Ser Leu Gln Thr Tyr Val Thr Gln Gln Leu Ile
115 120 125Arg Ala Ala Glu Ile Arg Ala Ser Ala Asn Leu Ala Ala Thr Lys Met
130 135 140Ser Glu Cys Val Leu145 149<210>42<211>150<212>PRT<213>SARS coronavirus<400>42Arg Ala Ser Ala Asn Leu Ala Ala Thr Lys Met Ser Glu Cys Val Leu1 5 10 15Gly Gln Ser Lys Arg Val Asp Phe Cys Gly Lys Gly Tyr His Leu Met
20 25 30Ser Phe Pro Gln Ala Ala Pro His Gly Val Val Phe Leu His Val Thr
35 40 45Tyr Val Pro Ser Gln Glu Arg Asn Phe Thr Thr Ala Pro Ala Ile Cys
50 55 60His Glu Gly Lys Ala Tyr Phe Pro Arg Glu Gly Val Phe Val Phe Asn65 70 75 80Gly Thr Ser Trp Phe Ile Thr Gln Arg Asn Phe Phe Ser Pro Gln Ile
85 90 95Ile Thr Thr Asp Asn Thr Phe Val Ser Gly Asn Cys Asp Val ValIle
100 105 110Gly Ile Ile Asn Asn Thr Val Tyr Asp Pro Leu Gln Pro Glu Leu Asp
115 120 125Ser Phe Lys Glu Glu Leu Asp Lys Tyr Phe Lys Asn His Thr Ser Pro
130 135 140Asp Val Asp Leu Gly Asp145 150<210>43<211>120<212>PRT<213>SARS coronavirus<400>43Lys Tyr Phe Lys Asn His Thr Ser Pro Asp Val Asp Leu Gly Asp Ile1 5 10 15Ser Gly Ile Asn Ala Ser Val Val Asn Ile Gln Lys Glu Ile Asp Arg
20 25 30Leu Asn Glu Val Ala Lys Asn Leu Asn Glu Ser Leu Ile Asp Leu Gln
35 40 45Glu Leu Gly Lys Tyr Glu Gln Tyr Ile Lys Trp Pro Trp Tyr Val Trp
50 55 60Leu Gly Phe Ile Ala Gly Leu Ile Ala Ile Val Met Val Thr Ile Leu65 70 75 80Leu Cys Cys Met Thr Ser Cys Cys Ser Cys Leu Lys Gly Ala Cys Ser
85 90 95Cys Gly Ser Cys Cys Lys Phe Asp Glu Asp Asp Ser Glu Pro Val Leu
100 105 110Lys Gly Val Lys Leu His Tyr Thr
115 120<210>44<211>15l<212>PRT<213>SARS coronavirus<400>44Thr Leu Gly Ser Ile Thr Ala Gln Pro Val Lys Ile Asp Asn Ala Ser1 5 10 15Pro Ala Ser Thr Val His Ala Thr Ala Thr Ile Pro Leu Gln Ala Ser
20 25 30Leu Pro Phe Gly Trp Leu Val Ile Gly Val Ala Phe Leu Ala Val Phe
35 40 45Gln Ser Ala Thr Lys Ile Ile Ala Leu Asn Lys Arg Trp Gln Leu Ala
50 55 60Leu Tyr Lys Gly Phe Gln Phe Ile Cys Asn Leu Leu Leu Leu Phe Val65 70 75 80Thr Ile Tyr Ser His Leu Leu Leu Val Ala Ala Gly Met Glu Ala Gln
85 90 95Phe Leu Tyr Leu Tyr Ala Leu Ile Tyr Phe Leu Gln Cys Ile Asn Ala
100 105 110Cys Arg Ile Ile Met Arg Cys Trp Leu Cys Trp Lys Cys Lys Ser Lys
115 120 125Asn Pro Leu Leu Tyr Asp Ala Asn Tyr Phe Val Cys Trp His Thr His
130 135 140Asn Tyr Asp Tyr Cys Ile Pro145 150 151<210>45<211>133<212>PRT<213>SARS coronavirus<400>45Asp Ala Asn Tyr Phe Val Cys Trp His Thr His Asn Tyr Asp Tyr Cys1 5 10 15Ile Pro Tyr Asn Ser Val Thr Asp Thr Ile Val Val Thr Glu Gly Asp
20 25 30Gly Ile Ser Thr Pro Lys Leu Lys Glu Asp Tyr Gln Ile Gly Gly Tyr
35 40 45Ser Glu Asp Arg His Ser Gly Val Lys Asp Tyr Val Val Val His Gly
50 55 60Tyr Phe Thr Glu Val Tyr Tyr Gln Leu Glu Ser Thr Gln Ile Thr Thr65 70 75 80Asp Thr Gly Ile Glu Asn Ala Thr Phe Phe Ile Phe Asn Lys Leu Val
85 90 95Lys Asp Pro Pro Asn Val Gln Ile His Thr Ile Asp Gly Ser Ser Gly
100 105 110Val Ala Asn Pro Ala Met Asp Pro Ile Tyr Asp Glu Pro Thr Thr Thr
115 120 125Thr Ser Val Pro Leu
130 133<210>46<211>83<212>PRT<213>SARS coronavirus<400>46Gln Glu Ser Glu Tyr Glu Leu Met Tyr Ser Phe Val Ser Glu Glu Thr1 5 10 15Glv Thr Leu Ile Val Asn Ser Val Leu Leu Phe Leu Ala Phe Val Val
20 25 30Phe Leu Leu Val Thr Leu Ala Ile Leu Thr Ala Leu Arg Leu Cys Ala
35 40 45Tyr Cys Cys Asn Ile Val Asn Val Ser Leu Val Lys Pro Thr Val Tyr
50 55 60Val Tyr Ser Arg Val Lys Asn Leu Asn Ser Ser Glu Gly Val Pro Asp65 70 75 80Leu Leu Val
83<210>47<211>150<212>PRT<213>SARS coronavirus<400>47Leu Leu Gln Phe Ala Tyr Ser Asn Arg Asn Arg Phe Leu Tyr Ile Ile1 5 10 15Lys Leu Val Phe Leu Trp Leu Leu Trp Pro Val Thr Leu Ala Cys Phe
20 25 30Val Leu Ala Ala Val Tyr Arg Ile Asn Trp Val Thr Gly Gly Ile Ala
35 40 45Ile Ala Met Ala Cys Ile Val Gly Leu Met Trp Leu Ser Tyr Phe Val
50 55 60Ala Ser Phe Arg Leu Phe Ala Arg Thr Arg Ser Met Trp Ser Phe Asn65 70 75 80Pro Glu Thr Asn Ile Leu Leu Asn Val Pro Leu Arg Gly Thr Ile Val
85 90 95Thr Arg Pro Leu Met Glu Ser Glu Leu Val Ile Gly Ala ValIle Ile
100 105 110Arg Gly His Leu Arg Met Ala Gly His Ser Leu Gly Arg Cys Asp Ile
115 120 125Lys Asp Leu Pro Lys Glu Ile Thr Val Ala Thr Ser Arg Thr Leu Ser
130 135 140Tyr Tyr Lys Leu Gly Ala145 150<210>48<211>55<212>PRT<213>SARS coronavirus<400>48Ile Thr Val Ala Thr Ser Arg Thr Leu Ser Tyr Tyr Lys Leu Gly Ala1 5 10 15Ser Gln Arg Val Gly Thr Asp Ser Gly Phe Ala Ala Tyr Asn Arg Tyr
20 25 30Arg Ile Gly Asn Tyr Lys Leu Asn Thr Asp His Ala Gly Ser Asn Asp
35 40 45Asn Ile Ala Leu Leu Val Gln
50 55<210>49<211>117<212>PRT<213>SARS coronavirus<400>49Phe Leu Thr Leu Ile Val Phe Thr Ser Cys Glu Leu Tyr His Tyr Gln1 5 10 15Glu Cys Val Arg Gly Thr Thr Val Leu Leu Lys Glu Pro Cys Pro Ser
20 25 30Gly Thr Tyr Glu Gly Asn Ser Pro Phe His Pro Leu Ala Asp Asn Lys
35 40 45Phe Ala Leu Thr Cys Thr Ser Thr His Phe Ala Phe Ala Cys Ala Asp
50 55 60Gly Thr Arg His Thr Tyr Gln Leu Arg Ala Arg Ser Val Ser Pro Lys65 70 75 80Leu Phe Ile Arg Gln Glu Glu Val Gln Gln Glu Leu Tyr Ser Pro Leu
85 90 95Phe Leu Ile Val Ala Ala Leu Val Phe Leu Ile Leu Cys Phe Thr Ile
100 105 110Lys Arg Lys Thr Glu
115 117<210>50<211>55<212>PRT<213>SARS coronavirus<400>50Ala Ile Pro Cys Phe Asn Asn Ala Tyr Tyr Ile Leu Val Phe Thr Arg1 5 10 15Asn Pro Gly Ser Arg Arg Thr Leu Tyr Gln Ser Leu Asn Glu His Glu
20 25 30Thr Ser His Cys Phe Asp Leu Tyr Phe Ser Met Gln Leu His Met His
35 40 45Cys Ser Thr Ala Leu Cys Ile
50 55<210>51<211>147<212>PRT<213>SARS coronavirus<400>51Ala Val Val Lys Thr Leu Gln Pro Val Ser Asp Leu Leu Thr Asn Met1 5 10 15Gly Ile Asp Leu Asp Glu Trp Ser Val Ala Thr Phe Tyr Leu Phe Asp
20 25 30Asp Ala Gly Glu Glu Asn Phe Ser Ser Arg Met Tyr Cys Ser Phe Tyr
35 40 45Pro Pro Asp Glu Glu Glu Glu Asp Asp Ala Glu Cys Glu Glu Glu Glu
50 55 60Ile Asp Glu Thr Cys Glu His Glu Tyr Gly Thr Glu Asp Asp Tyr Gln65 70 75 80Gly Leu Pro Leu Glu Phe Gly Ala Ser Ala Glu Thr Val Arg Val Glu
85 90 95Glu Glu Glu Glu Glu Asp Trp Leu Asp Asp Thr Thr Glu Gln Ser Glu
100 105 110Ile Glu Pro Glu Pro Glu Pro Thr Pro Glu Glu Pro Val Asn Gln Phe
115 120 125Thr Gly Tyr Leu Lys Leu Thr Asp Asn Val Ala Ile Lys Cys Val Asp
130 135 140Ile Val Lys145 147<210>52<211>146<212>PRT<213>SARS coronavirus<400>52Asn Glu Gln Ile Lys Met Ser Asp Asn Gly Pro Gln Ser Asn Gln Arg1 5 10 15Ser Ala Pro Arg Ile Thr Phe Gly Gly Pro Thr Asp Ser Thr Asp Asn
20 25 30Asn Gln Asn Gly Gly Arg Asn Gly Ala Arg Pro Lys Gln Arg Arg Pro
35 40 45Gln Gly Leu Pro Asn Asn Thr Ala Ser Trp Phe Thr Ala Leu Thr Gln
50 55 60His Gly Lys Glu Glu Leu Arg Phe Pro Arg Gly Gln Gly Val Pro Ile65 70 75 80Asn Thr Asn Ser Gly Pro Asp Asp Gln Ile Gly Tyr Tyr Arg Arg Ala
85 90 95Thr Arg Arg Val Arg Gly Gly Asp Gly Lys Met Lys Glu Leu Ser Pro
100 105 110Arg Trp Tyr Phe Tyr Tyr Leu Gly Thr Gly Pro Glu Ala Ser Leu Pro
115 120 125Tyr Gly Ala Asn Lys Glu Gly Ile Val Trp Val Ala Thr Glu Gly Ala
130 135 140Leu Asn145 146<210>53<211>147<212>PRT<213>SARS coronavirus<400>53Asn Lys Glu Gly Ile Val Trp Val Ala Thr Glu Gly Ala Leu Asn Thr1 5 10 15Pro Lys Asp His Ile Gly Thr Arg Asn Pro Asn Asn Asn Ala Ala Thr
20 25 30Val Leu Gln Leu Pro Gln Gly Thr Thr Leu Pro Lys Gly Phe Tyr Ala
35 40 45Glu Gly Ser Arg Gly Gly Ser Gln Ala Ser Ser Arg Ser Ser Ser Arg
50 55 60Ser Arg Gly Asn Ser Arg Asn Ser Thr Pro Gly Ser Ser Arg Gly Asn65 70 75 80Ser Pro Ala Arg Met Ala Ser Gly Gly Gly Glu Thr Ala Leu Ala Leu
85 90 95Leu Leu Leu Asp Arg Leu Asn Gln Leu Glu Ser Lys Val Ser Gly Lys
100 105 110Gly Gln Gln Gln Gln Gly Gln Thr Val Thr Lys Lys Ser Ala Ala Glu
115 120 125Ala Ser Lys Lys Pro Arg Gln Lys Arg Thr Ala Thr Lys Gln Tyr Asn
130 135 140Val Thr Gln145 147<210>54<211>146<212>PRT<213>SARS coronavirus<400>54Arg Gln Lys Arg Thr Ala Thr Lys Gln Tyr Asn Val Thr Gln Ala Phe1 5 10 15Gly Arg Arg Gly Pro Glu Gln Thr Gln Gly Asn Phe Gly Asp Gln Asp
20 25 30Leu Ile Arg Gln Gly Thr Asp Tyr Lys His Trp Pro Gln Ile Ala Gln
35 40 45Phe Ala Pro Ser Ala Ser Ala Phe Phe Gly Met Ser Arg Ile Gly Met
50 55 60Glu Val Thr Pro Ser Gly Thr Trp Leu Thr Tyr His Gly Ala Ile Lys65 70 75 80Leu Asp Asp Lys Asp Pro Gln Phe Lys Asp Asn Val Ile Leu Leu Asn
85 90 95Lys His Ile Asp Ala Tyr Lys Thr Phe Pro Pro Thr Glu Pro Lys Lys
100 105 110Asp Lys Lys Lys Lys Thr Asp Glu Ala Gln Pro Leu Pro Gln Arg Gln
115 120 125Lys Lys Gln Pro Thr Val Thr Leu Leu Pro Ala Ala Asp Met Asp Asp
130 135 140Phe Ser145 146<210>55<211>51<212>PRT<213>SARS coronavirus<400>55Asp Lys Lys Lys Lys Thr Asp Glu Ala Gln Pro Leu Pro Gln Arg Gln1 5 10 15Lys Lys Gln Pro Thr Val Thr Leu Leu Pro Ala Ala Asp Met Asp Asp
20 25 30Phe Ser Arg Gln Leu Gln Asn Ser Met Ser Gly Ala Ser Ala Asp Ser
35 40 45Thr Gln Ala
50 51<210>56<211>51<212>PRT<213>SARS coronavirus<400>56Asp Lys Lys Lys Lys Thr Asp Glu Ala Gln Pro Leu Pro Gln Arg Gln1 5 10 15Lys Lys Gln Pro Thr Val Thr Leu Leu Pro Ala Ala Asp Met Asp Asp
20 25 30Phe Ser Arg Gln Leu Gln Asn Ser Met Ser Gly Ala Ser Ala Asp Ser
35 40 45Thr Gln Ala
50 51<210>57<211>150<212>PRT<213>SARS coronavirus<400>57Tyr Leu Lys Leu Thr Asp Asn Val Ala Ile Lys Cys Val Asp Ile Val1 5 10 15Lys Glu Ala Gln Ser Ala Asn Pro Met Val Ile Val Asn Ala Ala Asn
20 25 30Ile His Leu Lys His Gly Gly Gly Val Ala Gly Ala Leu Asn Lys Ala
35 40 45Thr Asn Gly Ala Met Gln Lys Glu Ser Asp Asp Tyr Ile Lys Leu Asn
50 55 60Gly Pro Leu Thr Val Gly Gly Ser Cys Leu Leu Ser Gly His Asn Leu65 70 75 80Ala Lys Lys Cys Leu His Val Val Gly Pro Asn Leu Asn Ala Gly Glu
85 90 95Asp Ile Gln Leu Leu Lys Ala Ala Tyr Glu Asn Phe Asn Ser Gln Asp
100 105 110Ile Leu Leu Ala Pro Leu Leu Ser Ala Gly Ile Phe Gly Ala Lys Pro
115 120 125Leu Gln Ser Leu Gln Val Cys Val Gln Thr Val Arg Thr Gln Val Tyr
130 135 140Ile Ala Val Asn Asp Lys145 150<210>58<211>155<212>PRT<213>SARS coronavirus<400>58Leu Gln Ser Leu Gln Val Cys Val Gln Thr Val Arg Thr Gln Val Tyr1 5 10 15Ile Ala Val Asn Asp Lys Ala Leu Tyr Glu Gln Val Val Met Asp Tyr
20 25 30Leu Asp Asn Leu Lys Pro Arg Val Glu Ala Pro Lys Gln Glu Glu Pro
35 40 45Pro Asn Thr Glu Asp Ser Lys Thr Glu Glu Lys Ser Val Val Gln Lys
50 55 60Pro Val Asp Val Lys Pro Lys Ile Lys Ala Cys Ile Asp Glu Val Thr65 70 75 80Thr Thr Leu Glu Glu Thr Lys Phe Leu Thr Asn Lys Leu Leu Leu Phe
85 90 95Ala Asp Ile Asn Gly Lys Leu Tyr His Asp Ser Gln Asn Met Leu Arg
100 105 110Gly Glu Asp Met Ser Phe Leu Glu Lys Asp Ala Pro Tyr Met Val Gly
115 120 125Asp Val Ile Thr Ser Gly Asp Ile Thr Cys Val Val Ile Pro Ser Lys
130 135 140Lys Ala Gly Gly Thr Thr Glu Met Leu Ser Arg145 150 155<210>59<211>149<212>PRT<213>SARS coronavirus<400>59Leu Ser Thr Asn His Gly His Lys Val Val Glu Leu Val Ala Glu Met1 5 10 15Asp Gly Ile Gln Tyr Gly Arg Ser Gly Ile Thr Leu Gly Val Leu Val
20 25 30Pro His Val Gly Glu Thr Pro Ile Ala Tyr Arg Asn Val Leu Leu Arg
35 40 45Lys Asn Gly Asn Lys Gly Ala Gly Gly His Ser Tyr Gly Ile Asp Leu
50 55 60Lys Ser Tyr Asp Leu Gly Asp Glu Leu Gly Thr Asp Pro Ile Glu Asp65 70 75 80Tyr Glu Gln Asn Trp Asn Thr Lys His Gly Ser Gly Ala Leu Arg Glu
85 90 95Leu Thr Arg Glu Leu Asn Gly Gly Ala Val Thr Arg Tyr Val Asp Asn
100 105 110Asn Phe Cys Gly Pro Asp Gly Tyr Pro Leu Asp Cys Ile Lys Asp Phe
115 120 125Leu Ala Arg Ala Gly Lys Ser Met Cys Thr Leu Ser Glu Gln Leu Asp
130 135 140Tyr Ile Glu Ser Lys145 149<210>60<211>148<212>PRT<213>SARS coronavirus<400>60Val Ile Pro Ser Lys Lys Ala Gly Gly Thr Thr Glu Met Leu Ser Arg1 5 10 15Ala Leu Lys Lys Val Pro Val Asp Glu Tyr Ile Thr Thr Tyr Pro Gly
20 25 30Gln Gly Cys Ala Gly Tyr Thr Leu Glu Glu Ala Lys Thr Ala Leu Lys
35 40 45Lys Cys Lys Ser Ala Phe Tyr Val Leu Pro Ser Glu Ala Pro Asn Ala
50 55 60Lys Glu Glu Ile Leu Gly Thr Val Ser Trp Asn Leu Arg Glu Met Leu65 70 75 80Ala His Ala Glu Glu Thr Arg Lys Leu Met Pro Ile Cys Met Asp Val
85 90 95Arg Ala Ile Met Ala Thr Ile Gln Arg Lys Tyr Lys Gly Ile Lys Ile
100 105 110Gln Glu Gly Ile Val Asp Tyr Gly Val Arg Phe Phe Phe Tyr Thr Ser
115 120 125Lys Glu Pro Val Ala Ser Ile Ile Thr Lys Leu Asn Ser Leu Asn Glu
130 135 140Pro Leu Val Thr145 148<210>61<211>147<212>PRT<213>SARS coronavirus<400>61Thr Lys Leu Asn Ser Leu Asn Glu Pro Leu Val Thr Met Pro Ile Gly1 5 10 15Tyr Val Thr His Gly Phe Asn Leu Glu Glu Ala Ala Arg Cys Met Arg
20 25 30Ser Leu Lys Ala Pro Ala Val Val Ser Val Ser Ser Pro Asp Ala Val
35 40 45Thr Thr Tyr Asn Gly Tyr Leu Thr Ser Ser Ser Lys Thr Ser Glu Glu
50 55 60His Phe Val Glu Thr Val Ser Leu Ala Gly Ser Tyr Arg Asp Trp Ser
65 70 75 80Tyr Ser Gly Gln Arg Thr Glu Leu Gly Val Glu Phe Leu Lys Arg Gly
85 90 95Asp Lys Ile Val Tyr His Thr Leu Glu Ser Pro Val Glu Phe His Leu
100 105 110Asp Gly Glu Val Leu Ser Leu Asp Lys Leu Lys Ser Leu Leu Ser Leu
115 120 125Arg Glu Val Lys Thr Ile Lys Val Phe Thr Thr Val Asp Asn Thr Asn
130 135 140Leu His Thr145 147<210>62<211>147<212>PRT<213>SARS coronavirus<400>62Thr Lys Leu Asn Ser Leu Asn Glu Pro Leu Val Thr Met Pro Ile Gly1 5 10 15Tyr Val Thr His Gly Phe Asn Leu Glu Glu Ala Ala Arg Cys Met Arg
20 25 30Ser Leu Lys Ala Pro Ala Val Val Ser Val Ser Ser Pro Asp Ala Val
35 40 45Thr Thr Tyr Asn Gly Tyr Leu Thr Ser Ser Ser Lys Thr Ser Glu Glu
50 55 60His Phe Val Glu Thr Val Ser Leu Ala Gly Ser Tyr Arg Asp Trp Ser65 70 75 80Tyr Ser Gly Gln Arg Thr Glu Leu Gly Val Glu Phe Leu Lys Arg Gly
85 90 95Asp Lys Ile Val Tyr His Thr Leu Glu Ser Pro Val Glu Phe His Leu
100 105 110Asp Gly Glu Val Leu Ser Leu Asp Lys Leu Lys Ser Leu Leu Ser Leu
115 120 125Arg Glu Val Lys Thr Ile Lys Val Phe Thr Thr Val Asp Asn Thr Asn
130 135 140Leu His Thr145 147<210>63<211>149<212>PRT<213>SARS coronavirus<400>63Tyr Arg Ala Arg Ala Gly Asp Ala Ala Asn Phe Cys Ala Leu Ile Leu1 5 10 15Ala Tyr Ser Asn Lys Thr Val Gly Glu Leu Gly Asp Val Arg Glu Thr
20 25 30Met Thr His Leu Leu Gln His Ala Asn Leu Glu Ser Ala Lys Arg Val
35 40 45Leu Asn Val Val Cys Lys His Cys Gly Gln Lys Thr Thr Thr Leu Thr
50 55 60Gly Val Glu Ala Val Met Tyr Met Gly Thr Leu Ser Tyr Asp Asn Leu65 70 75 80Lys Thr Gly Val Ser Ile Pro Cys Val Cys Gly Arg Asp Ala Thr Gln
85 90 95Tyr Leu Val Gln Gln Glu Ser Ser Phe Val Met Met Ser Ala Pro Pro
100 105 110Ala Glu Tyr Lys Leu Gln Gln Gly Thr Phe Leu Cys Ala Asn Glu Tyr
115 120 125Thr Gly Asn Tyr Gln Cys Gly His Tyr Thr His Ile Thr Ala Lys Glu
130 135 140Thr Leu Tyr Arg Ile145 149<210>64<211>148<212>PRT<213>SARS coronavirus<400>64Cys Gly His Tyr Thr His Ile Thr Ala Lys Glu Thr Leu Tyr Arg Ile1 5 10 15Asp Gly Ala His Leu Thr Lys Met Ser Glu Tyr Lys Gly Pro Val Thr
20 25 30Asp Val Phe Tyr Lys Glu Thr Ser Tyr Thr Thr Thr Ile Lys Pro Val
35 40 45Ser Tyr Lys Leu Asp Gly Val Thr Tyr Thr Glu Ile Glu Pro Lys Leu
50 55 60Asp Gly Tyr Tyr Lys Lys Asp Asn Ala Tyr Tyr Thr Glu Gln Pro Ile65 70 75 80Asp Leu Val Pro Thr Gln Pro Leu Pro Asn Ala Ser Phe Asp Asn Phe
85 90 95Lys Leu Thr Cys Ser Asn Thr Lys Phe Ala Asp Asp Leu Asn Gln Met
100 105 110Thr Gly Phe Thr Lys Pro Ala Ser Arg Glu Leu Ser Val Thr Phe Phe
115 120 125Pro Asp Leu Asn Gly Asp Val Val Ala Ile Asp Tyr Arg His Tyr Ser
130 135 140Ala Ser Phe Lys145 148<210>65<211>151<212>PRT<213>SARS coronavirus<400>65Val Val Ala Ile Asp Tyr Arg His Tyr Ser Ala Ser Phe Lys Lys Gly1 5 10 15Ala Lys Leu Leu His Lys Pro Ile Val Trp His Ile Asn Gln Ala Thr
20 25 30Thr Lys Thr Thr Phe Lys Pro Asn Thr Trp Cys Leu Arg Cys Leu Trp
35 40 45Ser Thr Lys Pro Val Asp Thr Ser Asn Ser Phe Glu Val Leu Ala Val
50 55 60Glu Asp Thr Gln Gly Met Asp Asn Leu Ala Cys Glu Ser Gln Gln Pro65 70 75 80Thr Ser Glu Glu Val Val Glu Asn Pro Thr Ile Gln Lys Glu Val Ile
85 90 95Glu Cys Asp Val Lys Thr Thr Glu Val Val Gly Asn Val Ile Leu Lys
100 105 110Pro Ser Asp Glu Gly Val Lys Val Thr Gln Glu Leu Gly His Glu Asp
115 120 125Leu Met Ala Ala Tyt Val Glu Asn Thr Ser Ile Thr Ile Lys Lys Pro
130 135 140Asn Glu Leu Ser Leu Ala Leu145 150 151<210>66<211>146<212>PRT<213>SARS coronavirus<400>66Asn Thr Ser Ile Thr Ile Lys Lys Pro Asn Glu Leu Ser Leu Ala Leu1 5 10 15Gly Leu Lys Thr Ile Ala Thr His Gly Ile Ala Ala Ile Asn Ser Val
20 25 30Pro Trp Ser Lys Ile Leu Ala Tyr Val Lys Pro Phe Leu Gly Gln Ala
35 40 45Ala Ile Thr Thr Ser Asn Cys Ala Lys Arg Leu Ala Gln Arg Val Phe
50 55 60Asn Asn Tyr Met Pro Tyr Val Phe Thr Leu Leu Phe Gln Leu Cys Thr65 70 75 80Phe Thr Lys Ser Thr Asn Ser Arg Ile Arg Ala Ser Leu Pro Thr Thr
85 90 95Ile Ala Lys Asn Ser Val Lys Ser Val Ala Lys Leu Cys Leu Asp Ala
100 105 110Gly Ile Asn Tyr Val Lys Ser Pro Lys Phe Ser Lys Leu Phe Thr Ile
115 120 125Ala Met Trp Leu Leu Leu Leu Ser Ile Cys Leu Gly Ser Leu Ile Cys
130 135 140Val Thr145 146<210>67<211>151<212>PRT<213>SARS coronavirus<400>67Leu Leu Leu Leu Ser Ile Cys Leu Gly Ser Leu Ile Cys Val Thr Ala1 5 10 15Ala Phe Gly Val Leu Leu Ser Asn Phe Gly Ala Pro Ser Tyr Cys Asn
20 25 30Gly Val Arg Glu Leu Tyr Leu Asn Ser Ser Asn Val Thr Thr Met Asp
35 40 45Phe Cys Glu Gly Ser Phe Pro Cys Ser Ile Cys Leu Ser Gly Leu Asp
50 55 60Ser Leu Asp Ser Tyr Pro Ala Leu Glu Thr Ile Gln Val Thr Ile Ser65 70 75 80Ser Tyr Lys Leu Asp Leu Thr Ile Leu Gly Leu Ala Ala Glu Trp Val
85 90 95Leu Ala Tyr Met Leu Phe Thr Lys Phe Phe Tyr Leu Leu Gly Leu Ser
100 105 110Ala Ile Met Gln Val Phe Phe Gly Tyr Phe Ala Ser His Phe Ile Ser
115 120 125Asn Ser Trp Leu Met Trp Phe Ile Ile Ser Ile Val Gln Met Ala Pro
130 135 140Val Ser Ala Met Val Arg Met145 150 151<210>68<211>150<212>PRT<213>SARS coronavirus<400>68Leu Ser His Phe Val Asn Leu Asp Asn Leu Arg Ala Asn Asn Thr Lys1 5 10 15Gly Ser Leu Pro Ile Asn Val Ile Val Phe Asp Gly Lys Ser Lys Cys
20 25 30Asp Glu Ser Ala Ser Lys Ser Ala Ser Val Tyr Tyr Ser Gln Leu Met
35 40 45Cys Gln Pro Ile Leu Leu Leu Asp Gln Ala Leu Val Ser Asp Val Gly
50 55 60Asp Ser Thr Glu Val Ser Val Lys Met Phe Asp Ala Tyr Val Asp Thr65 70 75 80Phe Ser Ala Thr Phe Ser Val Pro Met Glu Lys Leu Lys Ala Leu Val
85 90 95Ala Thr Ala His Ser Glu Leu Ala Lys Gly Val Ala Leu Asp Gly Val
100 105 110Leu Ser Thr Phe Val Ser Ala Ala Arg Gln Gly Val Val Asp Thr Asp
115 120 125Val Asp Thr Lys Asp ValIle Glu Cys Leu Lys Leu Ser His His Ser
130 135 140Asp Leu Glu Val Thr Gly145 150<210>69<211>146<212>PRT<213>SARS coronavirus<400>69Cys Leu Lys Leu Ser His His Ser Asp Leu Glu Val Thr Gly Asp Ser1 5 10 15Cys Asn Asn Phe Met Leu Thr Tyr Asn Lys Val Glu Asn Met Thr Pro
20 25 30Arg Asp Leu Gly Ala Cys Ile Asp Cys Asn Ala Arg His Ile Asn Ala
35 40 45Gln Val Ala Lys Ser His Asn Val Ser Leu Ile Trp Asn Val Lys Asp
50 55 60Tyr Met Ser Leu Ser Glu Gln Leu Arg Lys Gln Ile Arg Ser Ala Ala65 70 75 80Lys Lys Asn Asn Ile Pro Phe Arg Leu Thr Cys Ala Thr Thr Arg Gln
85 90 95Val Val Asn Val Ile Thr Thr Lys Ile Ser Leu Lys Gly Gly Lys Ile
100 105 110Val Ser Thr Cys Phe Lys Leu Met Leu Lys Ala Thr Leu Leu Cys Val
115 120 125Leu Ala Ala Leu Val Cys Tyr Ile Val Met Pro Val His Thr Leu Ser
130 135 140Ile His145 146<210>70<211>150<212>PRT<213>SARS coronavirus<400>70Ser Met Cys Thr Leu Ser Glu Gln Leu Asp Tyr Ile Glu Ser Lys Arg1 5 10 15Gly Val Tyr Cys Cys Arg Asp His Glu His Glu Ile Ala Trp Phe Thr
20 25 30Glu Arg Ser Asp Lys Ser Tyr Glu His Gln Thr Pro Phe Glu Ile Lys
35 40 45Ser Ala Lys Lys Phe Asp Thr Phe Lys Gly Glu Cys Pro Lys Phe Val
50 55 60Phe Pro Leu Asn Ser Lys Val Lys Val Ile Gln Pro Arg Val Glu Lys65 70 75 80Lys Lys Thr Glu Gly Phe Met Gly Arg Ile Arg Ser Val Tyr Pro Val
85 90 95Ala Ser Pro Gln Glu Cys Asn Asn Met His Leu Ser Thr Leu Met Lys
100 105 110Cys Asn His Cys Asp Glu Val Ser Trp Gln Thr Cys Asp Phe Leu Lys
115 120 125Ala Thr Cys Glu His Cys Gly Thr Glu Asn Leu Val Ile Glu Gly Pro
130 135 140Thr Thr Cys Gly Tyr Leu145 150<210>71<211>150<212>PRT<213>SARS coronavirus<400>71Leu Leu Leu Ser Ile Cys Leu Gly Ser Leu Ile Cys Val Thr Ala Ala1 5 10 15Phe Gly Val Leu Leu Ser Asn Phe Gly Ala Pro Ser Tyr Cys Asn Gly
20 25 30Val Arg Glu Leu Tyr Leu Asn Ser Ser Asn Val Thr Thr Met Asp Phe
35 40 45Cys Glu Gly Ser Phe Pro Cys Ser Ile Cys Leu Ser Gly Leu Asp Ser
50 55 60Leu Asp Ser Tyr Pro Ala Leu Glu Thr Ile Gln Val Thr Ile Ser Ser65 70 75 80Tyr Lys Leu Asp Leu Thr Ile Leu Gly Leu Ala Ala Glu Trp Val Leu
85 90 95Ala Tyr Met Leu Phe Thr Lys Phe Phe Tyr Leu Leu Gly Leu Ser Ala
100 105 110Ile Met Gln Val Phe Phe Gly Tyr Phe Ala Ser His Phe Ile Ser Asn
115 120 125Ser Trp Leu Met Trp Phe Ile Ile Ser Ile Val Gln Met Ala Pro Val
130 135 140Ser Ala Met Val Arg Met145 150<210>72<211>149<212>PRT<213>SARS coronavirus<400>72Ser Thr Cys Phe Lys Leu Met Leu Lys Ala Thr Leu Leu Cys Val Leu1 5 10 15Ala Ala Leu Val Cys Tyr Ile Val Met Pro Val His Thr Leu Ser Ile
20 25 30His Asp Gly Tyr Thr Asn Glu Ile Ile Gly Tyr Lys Ala Ile Gln Asp
35 40 45Gly Val Thr Arg Asp Ile Ile Ser Thr Asp Asp Cys Phe Ala Asn Lys
50 55 60His Ala Gly Phe Asp Ala Trp Phe Ser Gln Arg Gly Gly Ser Tyr Lys65 70 75 80Asn Asp Lys Ser Cys Pro Val Val Ala Ala Ile Ile Thr Arg Glu Ile
85 90 95Gly Phe Ile Val Pro Gly Leu Pro Gly Thr Val Leu Arg Ala Ile Asn
100 105 110Gly Asp Phe Leu His Phe Leu Pro Arg Val Phe Ser Ala Val Gly Asn
115 120 125Ile Cys Tyr Thr Pro Ser Lys Leu Ile Glu Tyr Ser Asp Phe Ala Thr
130 135 140Ser Ala Cys Val Leu145 149<210>73<211>151<212>PRT<213>SARS coronavirus<400>73Thr Pro Ser Lys Leu Ile Glu Tyr Ser Asp Phe Ala Thr Ser Ala Cys1 5 10 15Val Leu Ala Ala Glu Cys Thr Ile Phe Lys Asp Ala Met Gly Lys Pro
20 25 30Val Pro Tyr Cys Tyr Asp Thr Asn Leu Leu Glu Gly Ser Ile Ser Tyr
35 40 45Ser Glu Leu Arg Pro Asp Thr Arg Tyr Val Leu Met Asp Gly Ser Ile
50 55 60Ile Gln Phe Pro Asn Thr Tyr Leu Glu Gly Ser Val Arg Val Val Thr65 70 75 80Thr Phe Asp Ala Glu Tyr Cys Arg His Gly Thr Cys Glu Arg Ser Glu
85 90 95Val Gly Ile Cys Leu Ser Thr Ser Gly Arg Trp Val Leu Asn Asn Glu
100 105 110His Tyr Arg Ala Leu Ser Gly Val Phe Cys Gly Val Asp Ala Met Asn
115 120 125Leu Ile Ala Asn Ile Phe Thr Pro Leu Val Gln Pro Val Gly Ala Leu
130 135 140Asp Val Ser Ala Ser Val Val145 150 151<210>74<211>154<212>PRT<213>SARS coronavirus<400>74Pro Leu Val Gln Pro Val Gly Ala Leu Asp Val Ser Ala Ser Val Val1 5 10 15Ala Gly Gly Ile Ile Ala Ile Leu Val Thr Cys Ala Ala Tyr Tyr Phe
20 25 30Met Lys Phe Arg Arg Val Phe Gly Glu Tyr Asn His Val Val Ala Ala
35 40 45Asn Ala Leu Leu Phe Leu Met Ser Phe Thr Ile Leu Cys Leu Val Pro
50 55 60Ala Tyr Ser Phe Leu Pro Gly Val Tyr Ser Val Phe Tyr Leu Tyr Leu65 70 75 80Thr Phe Tyr Phe Thr Asn Asp Val Ser Phe Leu Ala His Leu Gln Trp
85 90 95Phe Ala Met Phe Ser Pro Ile Val Pro Phe Trp Ile Thr Ala Ile Tyr
100 105 110Val Phe Cys Ile Ser Leu Lys His Cys His Trp Phe Phe Asn Asn Tyr
115 120 125Leu Arg Lys Arg Val Met Phe Asn Gly Val Thr Phe Ser Thr Phe Glu
130 135 140Glu Ala Ala Leu Cys Thr Phe Leu Leu Asn145 150 154<210>75<211>147<212>PRT<213>SARS coronavirus<400>75Phe Asn Gly Val Thr Phe Ser Thr Phe Glu Glu Ala Ala Leu Cys Thr1 5 10 15Phe Leu Leu Asn Lys Glu Met Tyr Leu Lys Leu Arg Ser Glu Thr Leu
20 25 30Leu Pro Leu Thr Gln Tyr Asn Arg Tyr Leu Ala Leu Tyr Asn Lys Tyr
35 40 45Lys Tyr Phe Ser Gly Ala Leu Asp Thr Thr Ser Tyr Arg Glu Ala Ala
50 55 60Cys Cys His Leu Ala Lys Ala Leu Asn Asp Phe Ser Asn Ser Gly Ala65 70 75 80Asp Val Leu Tyr Gln Pro Pro Gln Thr Ser Ile Thr Ser Ala Val Leu
85 90 95Gln Ser Gly Phe Arg Lys Met Ala Phe Pro Ser Gly Lys Val Glu Gly
100 105 110Cys Met Val Gln Val Thr Cys Gly Thr Thr Thr Leu Asn Gly Leu Trp
115 120 125Leu Asp Asp Thr Val Tyr Cys Pro Arg His Val Ile Cys Thr Ala Glu
130 135 140Asp Met Leu145 147<210>76<211>22<212>PRT<213>SARS coronavirus<400>76Lys Lys Met Ala Asp Asn Gly Thr Ile Thr Val Glu Glu Leu Lys Gln1 5 10 15Leu Leu Glu Gln Trp Asn
20 22<210>77<211>24<212>PRT<213>SARS coronavirus<400>77Lys Lys Leu Asn Val Pro Leu Arg Gly Thr Ile Val Thr Arg Pro Leu1 5 10 15Met Glu Ser Glu Leu Val Ile Gly
20 24<210>78<211>20<212>PRT<213>SARS coronavirus<400>78Lys Lys Arg Met Ala Gly His Ser Leu Gly Arg Cys Asp Ile Lys Asp1 5 10 15Leu Pro Lys Glu
20<210>79<211>18<212>PRT<213>SARS coronavirus<400>79Lys Lys Asn Thr Asp His Ala Gly Ser Asn Asp Asn Ile Ala Leu Leu1 5 10 15Val Gln
18<210>80<211>27<212>PRT<213>SARS coronavirus<400>80Lys Lys Lys Asp Gly Ile Tyr Phe Ala Ala Thr Glu Lys Ser Asn Val1 5 10 15Val Arg Gly Trp Val Phe Gly Ser Thr Met Asn
20 27<210>81<211>24<212>PRT<213>SARS coronavirus<400>81Lys Lys Trp Val Phe Gly Ser Thr Met Asn Asn Lys Ser Gln Ser Val1 5 10 15Ile Ile Ile Asn Asn Ser Thr Asn
20 24<210>82<211>24<212>PRT<213>SARS coronavirus<400>82Lys Lys Asp Cys Ser Gln Asn Pro Leu Ala Glu Leu Lys Cys Ser Val1 5 10 15Lys Ser Phe Glu Ile Asp Lys Gly
20 24<210>83<211>24<212>PRT<213>SARS coronavirus<400>83Lys Lys Gln Thr Ser Asn Phe Arg Val Val Pro Ser Gly Asp Val Val1 5 10 15Arg Phe Pro Asn Ile Thr Asn Leu
20 24<210>84<211>23<212>PRT<213>SARS coronavirus<400>84Lys Lys Pro Phe Gly Glu Val Phe Asn Ala Thr Lys Phe Pro Ser Val1 5 10 15Tyr Ala Trp Glu Arg Lys Lys
20 23<210>85<211>24<212>PRT<213>SARS coronavirus<400>85Lys Lys Gln Asp Val Asn Cys Thr Asp Val Ser Thr Ala Ile His Ala1 5 10 15Asp Gln Leu Thr Pro Ala Trp Arg
20 24<210>86<211>24<212>PRT<213>SARS coronavirus<400>86Lys Lys Thr Gly Asn Asn Val Phe Gln Thr Gln Ala Gly Cys Leu Ile1 5 10 15Gly Ala Glu His Val Asp Thr Ser
20 24<210>87<211>24<212>PRT<213>SARS coronavirus<400>87Lys Lys Lys Gly Ala Cys Ser Cys Gly Ser Cys Cys Lys Phe Asp Glu1 5 10 15Asp Asp Ser Glu Pro Val Leu Lys
20 24<210>88<211>25<212>PRT<213>SARS coronavirus<400>88Lys Lys Met Ser Asp Asn Gly Pro Gln Ser Asn Gln Arg Ser Ala Pro1 5 10 15Arg Ile Thr Phe Gly Gly Pro Thr Asp
20 25<210>89<211>24<212>PRT<213>SARS coronavirus<400>89Lys Lys Pro Thr Asp Ser Thr Asp Asn Asn Gln Asn Gly Gly Arg Asn1 5 10 15Gly Ala Arg Pro Lys Gln Arg Arg
20 24<210>90<211>24<212>PRT<213>SARS coronavirus<400>90Lys Lys Ser Arg Gly Gly Ser Gln Ala Ser Ser Arg Ser Ser Ser Arg1 5 10 15Ser Arg Gly Asn Ser Arg Asn Ser
20 24<210>91<211>24<212>PRT<213>SARS coronavirus<400>91Lys Lys Arg Asn Ser Thr Pro Gly Ser Ser Arg Gly Asn Ser Pro Ala1 5 10 15Arg Met Ala Ser Gly Gly Gly Glu
20 24<210>92<211>19<212>PRT<213>SARS coronavirus<400>92Lys Lys Lys Val Ser Gly Lys Gly Gln Gln Gln Gln Gly Gln Thr Val1 5 10 15Thr Lys Lys
19<210>93<211>22<212>PRT<213>SARS coronavirus<400>93Lys Lys Lys Asp Lys Lys Lys Lys Thr Asp Glu Ala Gln Pro Leu Pro1 5 10 15Gln Arg Gln Lys Lys Gln
20 22<210>94<211>24<212>PRT<213>SARS coronavirus<400>94Lys Lys Met Asp Asp Phe Ser Arg Gln Leu Gln Asn Ser Met Ser Gly1 5 10 15Ala Ser Ala Asp Ser Thr Gln Ala
20 24<210>95<211>25<212>PRT<213>SARS coronavirus<400>95Lys Lys Tyr Phe Val Ala Ser Phe Arg Leu Phe Ala Arg Thr Arg Ser1 5 10 15Met Try Ser Phe Asn Pro Glu Thr Asn
20 25<210>96<211>23<212>PRT<213>SARS coronavirus<400>96Lys Lys Tyr Arg Phe Asn Gly Ile Gly Val Thr Gln Asn Val Leu Tyr1 5 10 15Glu Asn Gln Lys Gln Ile Ala
20 23<210>97<211>20<212>PRT<213>SARS coronavirus<400>97Lys Lys Phe Lys Glu Glu Leu Asp Lys Tyr Phe Lys Asn His Thr Ser1 5 10 15Pro Asp Val Asp
20<210>98<211>24<212>PRT<213>SARS coronavirus<400>98Lys Lys Asp Gly Lys Met Lys Glu Leu Ser Pro Arg Trp Tyr Phe Tyr1 5 10 15Tyr Leu Gly Thr Gly Pro Glu Ala
20 24<210>99<211>24<212>PRT<213>SARS coronavirus<400>99Lys Lys Lys Pro Arg Gln Lys Arg Thr Ala Thr Lys Gln Tyr Asn Val1 5 10 15Thr Gln Ala Phe Gly Arg Arg Gly
20 24<210>100<211>27<212>PRT<213>SARS coronavirus<400>100Lys Lys Glu Gln Trp Asn Leu Val Ile Gly Phe Leu Phe Leu Ala Trp1 5 10 15Ile Met Leu Leu Gln Phe Ala Tyr Ser Asn Arg
20 25 27<210>101<211>24<212>PRT<213>SARS coronavirus<400>101Lys Lys Ala Arg Thr Arg Ser Met Trp Ser Phe Asn Pro Glu Thr Asn1 5 10 15Ile Leu Leu Asn Val Pro Leu Arg
20 24<210>102<211>23<212>PRT<213>SARS coronavirus<400>102Lys Lys Leu Val Ile Gly Ala Val Ile Ile Arg Gly His Leu Arg Met1 5 10 15Ala Gly His Ser Leu Gly Arg
20 23<210>103<211>27<212>PRT<213>SARS coronavirus<400>103Lys Lys Lys Asp Leu Pro Lys Glu Ile Thr Val Ala Thr Ser Arg Thr1 5 10 15Leu Ser Tyr Tyr Lys Leu Gly Ala Ser Gln Arg
20 25 27<210>104<211>25<212>PRT<213>SARS coronavirus<400>104Lys Lys Asp Ser Gly Phe Ala Ala Tyr Asn Arg Tyr Arg Ile Gly Asn1 5 10 15Tyr Lys Leu Asn Thr Asp His Ala Gly
20 25<210>105<211>25<212>PRT<213>SARS coronavirus<400>105Lys Lys Thr Gly Phe His Thr Ile Asn His Thr Phe Gly Asn Pro Val1 5 10 15Ile Pro Phe Lys Asp Gly Ile Tyr Phe
20 25<210>106<211>27<212>PRT<213>SARS coronavirus<400>106Lys Lys Asn Asn Ser Thr Asn Val Val Ile Arg Ala Cys Asn Phe Glu1 5 10 15Leu Cys Asp Asn Pro Phe Phe Ala Val Ser Lys
20 25 27<210>107<211>24<212>PRT<213>SARS coronavirus<400>107Lys Lys Thr Thr Phe Met Leu Lys Tyr Asp Glu Asn Gly Thr Ile Thr1 5 10 15Asp Ala Val Asp Cys Ser Gln Asn
20 24<210>108<211>24<212>PRT<213>SARS coronavirus<400>108Lys Lys Ile Ser Asn Cys Val Ala Asp Tyr Ser Val Leu Tyr Asn Ser1 5 10 15Thr Phe Phe Ser Thr Phe Lys Cys
20 24<210>109<211>25<212>PRT<213>SARS coronavirus<400>109Lys Lys Ser Val Ile Thr Pro Gly Thr Asn Ala Ser Ser Glu Val Ala1 5 10 15Val Leu Tyr Gln Asp Val Asn Cys Thr
20 25<210>110<211>25<212>PRT<213>SARS coronavirus<400>110Lys Lys Ser Tyr Glu Cys Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala1 5 10 15Ser Tyr His Thr Val Ser Leu Leu Arg
20 25<210>111<211>24<212>PRT<213>SARS coronavirus<400>111Lys Lys Met Val Thr Ile Leu Leu Cys Cys Met Thr Ser Cys Cys Ser1 5 10 15Cys Leu Lys Gly Ala Cys Ser Cys
20 24<210>112<211>24<212>PRT<213>SARS coronavirus<400>112Lys Lys Ser Cys Cys Lys Phe Asp Glu Asp Asp Ser Glu Pro Val Leu1 5 10 15Lys Gly Val Lys Leu His Tyr Thr
20 24<210>113<211>24<212>PRT<213>SARS coronavirus<400>113Lys Lys Gly Ala Arg Pro Lys Gln Arg Arg Pro Gln Gly Leu Pro Asn1 5 10 15Asn Thr Ala Ser Trp Phe Thr Ala
20 24<210>114<211>24<212>PRT<213>SARS coronavirus<400>114Lys Lys Gln Leu Pro Gln Gly Thr Thr Leu Pro Lys Gly Phe Tyr Ala1 5 10 15Glu Gly Ser Arg Gly Gly Ser Gln
20 24<210>115<211>27<212>PRT<213>SARS coronavirus<400>115Lys Lys Gly Gly Glu Thr Ala Leu Ala Leu leu leu Leu Asp Arg Leu1 5 10 15Asn Gln Leu Glu Ser Lys Val Ser Gly Lys Gly
20 25 27<210>116<211>26<212>PRT<213>SARS coronavirus<400>116Lys Lys Gln Thr Val Thr Lys Lys Ser Ala Ala Glu Ala Ser Lys Lys1 5 10 15Pro Arg Gln Lys Arg Thr Ala Thr Lys Gln
20 26<210>117<211>24<212>PRT<213>SARS coronavirus<400>117Lys Lys Asn Lys His Ile Asp Ala Tyr Lys Thr Phe Pro Pro Thr Glu1 5 10 15Pro Lys Lys Asp Lys Lys Lys Lys
20 24<210>118<211>25<212>PRT<213>SARS coronavirus<400>118Lys Lys Gln Arg Gln Lys Lys Gln Pro Thr Val Thr Leu Leu Pro Ala1 5 10 15Ala Asp Met Asp Asp Phe Ser Arg Gln
20 25
Claims (3)
1、一种非典型性肺炎病毒特异蛋白质，其特征在于：它包括非典型性肺炎病毒的蛋白质和经修饰的重组非典型性肺炎病毒蛋白质，或其具有结合人免疫球蛋白之免疫活性的片段或衍生物，具有通式Seq.ID No.1-Seq.ID No.118的氨基酸序列的蛋白质。
2、根据权利要求1所述的蛋白质相对应的抗体，其特征在于：所述说的蛋白质相对应的抗是单克隆抗体，或是多克隆抗体。
3、一种非典型性肺炎病毒特异蛋白质临床检测方法，其特征在于其具体步骤如下：
1)制备如权利要求1所述的蛋白质；
通过本领域技术人员周知的PCR扩增技术和重组DNA技术，具体如下：
A、设计相应的PCR引物，同时在所用PCR引物中添加编码相应数目氨基酸残基对应的碱基，分别从临床非典型性肺炎病毒标准株中扩增编码上述蛋白质的DNA片段；
B、将所得PCR产物导入合适的表达载体，构建重组DNA；
C、用所得重组DNA转化合适的宿主细胞，在适于目标蛋白质表达的条件下培养如此转化的宿主细胞；
D、回收并纯化目标蛋白质；
2)用纯化的如权利要求1所述的蛋白质，或如权利要求2所述的抗体包被一种固相支持物；所说的固相支持物包括本领域周知的有机和无机多聚物，为葡聚糖、天然或经修饰的纤维素、聚乙烯、聚苯乙烯；或用胶体金的方法包被到试纸上；
3)用比色法、分光光度法或荧光法测定的酶标记如权利要求1所述的蛋白质或权利要求2所述的抗体，或权利要求2所述的抗体的第二抗体(IgG、IgM、IgA)；标记酶包括氧化还原酶类，为催化酶、过氧化物酶、辣根过氧化物酶、葡萄糖氧化酶、β-半乳糖苷酶；碱性磷酸酶；乙酰胆碱酯酶；使用胶体金，或放射性同位素作为标记；
4)将待检测个体的生物学样本及由步骤3)标记的蛋白质加入经包被的固相支持物上，在适合形成抗原抗体免疫结合复合物的条件下孵育一段时间；
5)适度清洗去除任何未结合的非典型性肺炎病毒抗体；
6)定量检测孵育混合物中抗原抗体免疫复合物的存在。
4、一种非典型性肺炎病毒特异蛋白质临床检测的试剂盒，其特征在于包括：
1)包被有纯化的如权利要求1所述的蛋白质的固相支持物；相应的经标记的如权利要求1所述的蛋白质和使用该试剂盒的说明；
2)包被有纯化的如权利要求2所述的抗体的固相支持物；相应的经标记的如权利要求2所述的抗体和使用该试剂盒的说明；
3)包被有纯化的如权利要求1所述的蛋白质的固相支持物；如上文所述标记的第二抗体，该第二抗体可以是抗IgG抗体和/或抗IgM抗体和使用该试剂盒的说明；
5、根据权利要求4所述的一种非典型性肺炎病毒特异蛋白质临床检测的试剂盒，其特征在于：所说的快速检测非典型性肺炎病毒的试纸，是由喷涂过如权利要求1所述的蛋白或权利要求2所述的抗体，及喷涂有胶体金的试纸基质粘合而成；
在上述检测试剂盒中，经标记的非典型性肺炎病毒蛋白质是液体的形式包装在容器中，或便于重构的冻干物的形式置于的包装中。在后一种情况中，检测试剂盒中还优选含有用于重构经标记的非典型性肺炎病毒蛋白质的缓冲液；
在上述检测试剂盒中，还含有提供判断检测结果的相应的范围。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03116657 CN1216902C (zh) | 2003-04-26 | 2003-04-26 | 非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03116657 CN1216902C (zh) | 2003-04-26 | 2003-04-26 | 非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1483737A true CN1483737A (zh) | 2004-03-24 |
| CN1216902C CN1216902C (zh) | 2005-08-31 |
Family
ID=34152613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03116657 Expired - Lifetime CN1216902C (zh) | 2003-04-26 | 2003-04-26 | 非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1216902C (zh) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006085933A3 (en) * | 2004-06-17 | 2007-03-08 | Becton Dickinson Co | Immunogenic domains of sars coronavirus |
| US7521185B2 (en) | 2003-09-12 | 2009-04-21 | Becton, Dickinson And Company | Assay for SARS coronavirus by amplification and detection of the replicase sequence |
| US20110262529A1 (en) * | 2008-11-28 | 2011-10-27 | Nof Corporation | Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof |
| WO2019024148A1 (zh) * | 2017-07-31 | 2019-02-07 | 南京医科大学第一附属医院 | 用于检测乙酰胆碱酯酶的胶体金层析快速诊断试纸条及其制备方法 |
| CN112592385A (zh) * | 2020-12-02 | 2021-04-02 | 杭州百凌生物科技有限公司 | 一种人工多肽组合物、其抗体及在病理检测中的应用 |
| CN113214374A (zh) * | 2020-02-06 | 2021-08-06 | 深圳华大基因股份有限公司 | 一种包虫病新抗原Cystatin蛋白 |
| CN113238048A (zh) * | 2021-05-11 | 2021-08-10 | 上海真测生物科技有限公司 | 一种诊断标志物及其在区分新冠病毒感染和新冠病毒灭活疫苗接种中的应用 |
| CN114605506A (zh) * | 2022-04-08 | 2022-06-10 | 湖南大学 | 冠状病毒m蛋白胞外域多肽及其应用 |
-
2003
- 2003-04-26 CN CN 03116657 patent/CN1216902C/zh not_active Expired - Lifetime
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521185B2 (en) | 2003-09-12 | 2009-04-21 | Becton, Dickinson And Company | Assay for SARS coronavirus by amplification and detection of the replicase sequence |
| US7723041B2 (en) | 2003-09-12 | 2010-05-25 | Becton, Dickinson And Company | Assay for SARS coronavirus by amplification and detection of the replicase sequence |
| WO2006085933A3 (en) * | 2004-06-17 | 2007-03-08 | Becton Dickinson Co | Immunogenic domains of sars coronavirus |
| EP2000476A3 (en) * | 2004-06-17 | 2009-04-08 | Becton, Dickinson & Company | Immunogenic domains of sars coronavirus |
| US20110262529A1 (en) * | 2008-11-28 | 2011-10-27 | Nof Corporation | Cytotoxic t cell epitope peptide for sars coronavirus, and use thereof |
| US8828929B2 (en) * | 2008-11-28 | 2014-09-09 | Nof Corporation | Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof |
| WO2019024148A1 (zh) * | 2017-07-31 | 2019-02-07 | 南京医科大学第一附属医院 | 用于检测乙酰胆碱酯酶的胶体金层析快速诊断试纸条及其制备方法 |
| CN113214374A (zh) * | 2020-02-06 | 2021-08-06 | 深圳华大基因股份有限公司 | 一种包虫病新抗原Cystatin蛋白 |
| CN113214374B (zh) * | 2020-02-06 | 2022-08-26 | 深圳华大基因股份有限公司 | 一种包虫病新抗原Cystatin蛋白 |
| CN112592385A (zh) * | 2020-12-02 | 2021-04-02 | 杭州百凌生物科技有限公司 | 一种人工多肽组合物、其抗体及在病理检测中的应用 |
| CN112592385B (zh) * | 2020-12-02 | 2023-02-03 | 杭州百凌生物科技有限公司 | 一种人工多肽组合物、其抗体及在病理检测中的应用 |
| CN113238048A (zh) * | 2021-05-11 | 2021-08-10 | 上海真测生物科技有限公司 | 一种诊断标志物及其在区分新冠病毒感染和新冠病毒灭活疫苗接种中的应用 |
| CN113238048B (zh) * | 2021-05-11 | 2024-03-15 | 抗码(苏州)生物科技有限公司 | 一种诊断标志物及其在区分新冠病毒感染和新冠病毒灭活疫苗接种中的应用 |
| CN114605506A (zh) * | 2022-04-08 | 2022-06-10 | 湖南大学 | 冠状病毒m蛋白胞外域多肽及其应用 |
| CN114605506B (zh) * | 2022-04-08 | 2024-05-07 | 湖南大学 | 冠状病毒m蛋白胞外域多肽及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1216902C (zh) | 2005-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1266275C (zh) | 重组己糖氧化酶和其产生方法及用途 | |
| CN1930474A (zh) | 变应原的检测方法 | |
| CN1072726C (zh) | 利用聚合酶链反应检测真菌病原菌 | |
| CN1617927A (zh) | 焦谷氨酰肽酶及其基因 | |
| CN1437653A (zh) | 抗原多肽 | |
| CN1440419A (zh) | 治疗和预防细菌感染的化合物和方法 | |
| CN1515669A (zh) | 由氧化葡糖杆菌t-100得到的l-山梨酮脱氢酶 | |
| CN1203180C (zh) | 来自脑膜炎奈瑟氏球菌的basb006多核苷酸和多肽 | |
| CN101033468A (zh) | 幽门螺杆菌尿素酶b亚单位b细胞抗原表位多肽及鉴定方法与应用 | |
| CN1206352C (zh) | 木聚糖酶在制备食品中的用途 | |
| CN1244769A (zh) | 抗微生物蛋白 | |
| CN1221453A (zh) | 提高丝状真菌中血红素蛋白产量的方法 | |
| CN1483737A (zh) | 非典型性肺炎病毒特异蛋白质和临床检测的方法及试剂盒 | |
| CN1136328A (zh) | 具有减弱的蛋白酶活性的嗜血杆菌Hin47类似物 | |
| CN1133594A (zh) | 单纯性疱疹病毒-2ul26基因，衣壳蛋白，免疫测定和蛋白酶抑制剂 | |
| CN1111909A (zh) | 新多肽及编码该多肽的dna | |
| CN1458976A (zh) | 2,5－dkg通透酶 | |
| CN1156491C (zh) | 经修饰的梅毒螺旋体外膜蛋白质,其免疫检测应用和含有它的试剂盒 | |
| CN1434867A (zh) | 具有各种特性的稻子过氧化物酶 | |
| CN1289523C (zh) | 水稻钾、钠离子转运基因及其应用 | |
| CN1629188A (zh) | 日本血吸虫的特异性抗原及用途 | |
| CN1763203A (zh) | 一种基因重组人巨细胞病毒融合蛋白pp150/MDBP及其制备方法与应用 | |
| CN1304426C (zh) | 信号系统及其使用的元件 | |
| CN1816562A (zh) | 封闭效率提高的蛋白质 | |
| CN1258317A (zh) | 登革病毒基因表达的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING HUADA JIBIAI BIOLOGY TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: HANGZHOU GENOMICS R + D CENTER Effective date: 20081010 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20081010 Address after: No. 6, B District, Beijing Airport Development Zone Patentee after: BEIJING GBI BIOTECHNOLOGY Co.,Ltd. Address before: No. 13 West Mountain Road, Hangzhou, Zhejiang, Xihu District Patentee before: HUADA GENE RES AND DEV CT HANG |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Specific protein of SARS virus, clinical detection method and kit Effective date of registration: 20130620 Granted publication date: 20050831 Pledgee: Industrial Commercial Bank of China Ltd. Beijing Shunyi branch Pledgor: BEIJING GBI BIOTECHNOLOGY Co.,Ltd. Registration number: 2013990000388 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20150716 Granted publication date: 20050831 Pledgee: Industrial Commercial Bank of China Ltd. Beijing Shunyi branch Pledgor: BEIJING GBI BIOTECHNOLOGY Co.,Ltd. Registration number: 2013990000388 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20050831 |
|
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Yu Yan Document name: Notice of Termination of Patent Rights |